Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Dermatology

  Free Subscription


Articles published in J Invest Dermatol

Retrieve available abstracts of 738 articles:
HTML format



Single Articles


    April 2027
  1. SAINT-ANTOINE MM, El-Houni Z, Newton VL, Bradley EJ, et al
    Comparative circadian transcriptome analysis reveals dampened and phase-advanced rhythms in sun-exposed human skin.
    J Invest Dermatol. 2027 Apr 2:S0022-202X(26)01042.
    PubMed     Abstract available


    July 2026
  2. DUZ T, Torocsik D, Momnougui SME, Oubounyt M, et al
    An Integrated Skin Cell Atlas Decodes the Pilosebaceous Unit.
    J Invest Dermatol. 2026 Jul 2:S0022-202X(26)02662.
    PubMed     Abstract available


  3. YANG Y, Xu Z, Wu X, Xuan Y, et al
    Clinical characteristics, outcome, and costs among patients in a dermatological intensive care unit: A single-center retrospective study.
    J Invest Dermatol. 2026;146:1887-1895.
    PubMed     Abstract available


  4. CECCACCI S, Roger K, Marchal L, Ragot H, et al
    Proteomics reveals altered lipid biosynthesis and keratin hyperphosphorylation in pachyonychia congenita.
    J Invest Dermatol. 2026;146:1906-1917.
    PubMed     Abstract available


  5. PEACKER BL, Ly L, Hwang JC, Gravel-Pucillo K, et al
    Multiomics analyses prioritize disease genes and pathways in hidradenitis suppurativa.
    J Invest Dermatol. 2026;146:1807-1815.
    PubMed     Abstract available


  6. WANG Y, Qin D, Jiang X, Yin D, et al
    Inhibitory regulation of itch and associated negative emotions by ventral hippocampal neurons in rats.
    J Invest Dermatol. 2026;146:1930-1944.
    PubMed     Abstract available


  7. DIAZ D, Vazquez T, Kodali N, Bashir MM, et al
    Lenabasum, a cannabinoid type 2 receptor agonist, exerts anti-inflammatory effects in dermatomyositis.
    J Invest Dermatol. 2026;146:1827-1836.
    PubMed     Abstract available


  8. HE T, Wang Y, Yu G, Dong E, et al
    Myeloid-driven inflammation highlights ADGRE2 as a biomarker in prurigo nodularis: Integrated multiomics analysis.
    J Invest Dermatol. 2026;146:1918-1929.
    PubMed     Abstract available


  9. LIM SS, Zhao P, Wong NC, Szeto P, et al
    Evaluation of clonality in lentigo maligna.
    J Invest Dermatol. 2026;146:1955-1965.
    PubMed     Abstract available


  10. WANG Y, Wang Z, Lv S, Huang Q, et al
    OCA2 deficiency enhances TPC2 channel activity to reduce melanosomal pH and pigment production.
    J Invest Dermatol. 2026;146:2001-2015.
    PubMed     Abstract available


  11. DORFER S, Zauner R, Guttmann-Gruber C, Reichl V, et al
    Transcriptome-guided drug repurposing identifies selumetinib for an aggressive epithelial cancer.
    J Invest Dermatol. 2026;146:1978-1988.
    PubMed     Abstract available


  12. SENNETT ML, Feehan RP, Wallace TE, Gettle SL, et al
    Connectivity mapping with isotretinoin's transcriptomic signature identifies alternative therapeutics for severe acne.
    J Invest Dermatol. 2026;146:1876-1886.
    PubMed     Abstract available


  13. ELSBROEK L, Reuschlein K, Karsai S, Geueke A, et al
    Primary keratinocyte model of actinic keratosis reveals UV-induced DNA damage accumulation and persistent IFN signaling.
    J Invest Dermatol. 2026;146:1837-1850.
    PubMed     Abstract available


  14. PANDYA AG, Lynde CW, Shayesteh Alam M, Thorla IH, et al
    Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo.
    J Invest Dermatol. 2026;146:1867-1875.
    PubMed     Abstract available


  15. WILLIAMS MN, Joffe D, Mandel J, Schepps S, et al
    Spatial transcriptomics uncovers unique tumor microenvironments in folliculotropic versus classic mycosis fungoides.
    J Invest Dermatol. 2026;146:1945-1954.
    PubMed     Abstract available


    June 2026
  16. GHAHARI N, Zheng L, Kuppanda PM, Chandra SS, et al
    Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.
    J Invest Dermatol. 2026 Jun 29:S0022-202X(26)02660.
    PubMed    


  17. SEISER S, Brezovec H, Penninger P, Phan-Canh T, et al
    Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02659.
    PubMed     Abstract available


  18. SHAKIBA S, Okinedo I, Salam N, Li M, et al
    Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02657.
    PubMed     Abstract available


  19. CASSIDY PB, Berry EG, Samatham R, Mengden S, et al
    The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02625.
    PubMed     Abstract available


  20. ARMSTRONG AW, Roberts AM, Kostandy G, Choudhury F, et al
    Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02656.
    PubMed     Abstract available


  21. LV M, Yang F, Jiang C, Man XY, et al
    Cellular immunotherapy in psoriasis: Chimeric antigen receptor-based strategies and emerging approaches to immune reset.
    J Invest Dermatol. 2026 Jun 20:S0022-202X(26)01268.
    PubMed    


  22. LOUBNA O, Papouin B, Lamaison C, Ingen-Housz-Oro S, et al
    IL4I1+ Macrophage Accumulation in Advanced Cutaneous T-Cell Lymphomas Suggests a Role in Tumor Immune Escape.
    J Invest Dermatol. 2026 Jun 17:S0022-202X(26)02613.
    PubMed    


  23. ZHOU T, Geng S
    Breaking the mast cell-T helper 2 axis in atopic dermatitis: Insights from oral MRGPRX2 antagonist.
    J Invest Dermatol. 2026 Jun 17:S0022-202X(26)01263.
    PubMed    


  24. PARAGH G, Murakami M, Fitzgerald ME, Yan L, et al
    Topical 5-fluorouracil versus photodynamic therapy: differential impact on epidermal clonal mutations in early UV-induced skin carcinogenesis.
    J Invest Dermatol. 2026 Jun 15:S0022-202X(26)02608.
    PubMed    


  25. KUNSTNER A, Abdelhamid A, Casetti F, Rodriguez E, et al
    Cutaneous dysbiosis in inherited ichthyoses/epidermal differentiation disorders: a prospective case-control study.
    J Invest Dermatol. 2026 Jun 13:S0022-202X(26)02603.
    PubMed    


  26. RAYMUNDO JR, Senapati B, Zhu W, Lin AE, et al
    KCTD1/KCTD15 Complexes Repress AP-2alpha and AP-2beta to Regulate Neural Crest-Dependent Craniofacial Morphogenesis and Scalp Skin Development.
    J Invest Dermatol. 2026 Jun 12:S0022-202X(26)02600.
    PubMed     Abstract available


  27. ZEHTAB M, French LE, Lim HW, Fuller LC, et al
    A global health mandate for skin biology: Research opportunities for improved care after the World Health Assembly (WHA) skin diseases resolution.
    J Invest Dermatol. 2026 Jun 11:S0022-202X(26)01199.
    PubMed    


  28. KING AD, Fisher DE
    Identifying the drivers of genetic risk in patients with multiple primary melanoma.
    J Invest Dermatol. 2026 Jun 11:S0022-202X(26)01008.
    PubMed    


  29. TAN SJ, Law CLD, Low S, Keith Tan KX, et al
    Development and applications of primary human sebocyte-derived sebaceous gland organoids: Sebaceous gland organoids.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01051.
    PubMed     Abstract available


  30. GROSS L, Buddenkotte J, Joy F, Jochebeth A, et al
    Microdialysis-based metabolomic and proteomic profiling reveals signature variations for disease severity in psoriasis.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01192.
    PubMed     Abstract available


  31. RAMESSUR R, Gelfand JM
    Trials and tribulations of systemic inflammation and cardiovascular risk in psoriasis.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01206.
    PubMed    


  32. CALVAO J, Iselin C, Wasmayr J, Furtmuller C, et al
    Pathogenesis of cutaneous T-cell lymphoma: Malignant inflammation, immune reprogramming, and microenvironmental drivers.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01032.
    PubMed     Abstract available


  33. SACKNOVITZ Y, Ma R, Zhou MH, Kent J, et al
    Serum proteomic and single-cell transcriptomic profiling reveals immunoproteomic features distinguishing early-stage mycosis fungoides from atopic dermatitis.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)02599.
    PubMed    


  34. KOSUMI H, Rim C, Ito M
    Retinoic acids shift skin stem cell fate.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)01049.
    PubMed    


  35. ZHAO Q, Leguina-Ruzzi A, Tominaga M, Kamata Y, et al
    Psychological stress delays inflammatory resolution and promotes sustained sensory sensitization during recovery from atopic dermatitis.
    J Invest Dermatol. 2026 Jun 9:S0022-202X(26)02596.
    PubMed    


  36. RIEBELMANN J, Schittek B
    The role of neutrophils and neutrophil extracellular traps in Staphylococcus aureus colonization in healthy and inflamed skin.
    J Invest Dermatol. 2026 Jun 9:S0022-202X(26)01050.
    PubMed     Abstract available


  37. WANG Y, Amber KT
    Hiding in plain sight: Pathogenic insights from nonlesional skin in gliptin-associated bullous pemphigoid.
    J Invest Dermatol. 2026 Jun 9:S0022-202X(26)01007.
    PubMed    


  38. HOU P, Che Y, Han J, Deming C, et al
    Permissive skin microbiomes in WHIM syndrome: HPV and pathogen expansion.
    J Invest Dermatol. 2026 Jun 8:S0022-202X(26)01309.
    PubMed     Abstract available


  39. DLOVA NC, Cole-Adeife OM, Enechukwu NA, Madhumita M, et al
    The rise of the skin bleaching crisis: global perspectives.
    J Invest Dermatol. 2026 Jun 6:S0022-202X(26)01180.
    PubMed     Abstract available


  40. PETERS RHW, Smits JPH, van den Bogaard EH, Kelemen E, et al
    Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
    J Invest Dermatol. 2026 Jun 5:S0022-202X(26)01200.
    PubMed     Abstract available


  41. KIM N, Petukhova L, Winter DC, Tobin DJ, et al
    Activation of epidermal melanocytes in Hidradenitis Suppurativa.
    J Invest Dermatol. 2026 Jun 4:S0022-202X(26)01278.
    PubMed    


  42. HAN J, Lisco A, Che Y, Anderson MV, et al
    Expansion of pathogens and restoration of human skin microbiome in CD4 T-cell lymphopenia.
    J Invest Dermatol. 2026 Jun 3:S0022-202X(26)01274.
    PubMed     Abstract available


  43. EZZEDINE K, Eleftheriadou V, Harboe J
    When light turns skin: The eruption of black in Rothko's late paintings (Mark Rothko, Untitled [Black on Gray], 1969-1970).
    J Invest Dermatol. 2026 Jun 3:S0022-202X(26)01026.
    PubMed    


  44. HOLTAPPELS E, van Uden NOP, Chielie S, Narayan VS, et al
    Revealing Biological Mechanisms of Skin Pigment Recovery during Treatment in Vitiligo Patients; A Proteomic Analysis.
    J Invest Dermatol. 2026 Jun 2:S0022-202X(26)01272.
    PubMed     Abstract available


  45. SHEN N, Fang Q, Xuan Y, Liu Y, et al
    Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications.
    J Invest Dermatol. 2026;146:1501-1513.
    PubMed     Abstract available


  46. ONO N, Ito Y, Aoki S, Shiohama A, et al
    Microbial dysbiosis and foot odor in Nagashima-type palmoplantar keratosis: Improvement with topical benzoyl peroxide.
    J Invest Dermatol. 2026;146:1586-1595.
    PubMed     Abstract available


  47. ZHANG L, Lun L, Shen M, Zhai W, et al
    Multiomics reveals CCL3-driving neuronal sensitization in chronic pruritus of unknown origin.
    J Invest Dermatol. 2026;146:1617-1627.
    PubMed     Abstract available


  48. RAYMUNDO JR, Makkar J, Fasci MG, Driskell RR, et al
    TGFalpha is required for hair follicle function during aging and its loss leads to progressive alopecia.
    J Invest Dermatol. 2026;146:1527-1541.
    PubMed     Abstract available


  49. NAZIR ZH, Manci R, Nanda JK, Dusza SW, et al
    Diagnostic performance of electrical impedance spectroscopy in patients with multiple nevi and large acquired nevi.
    J Invest Dermatol. 2026;146:1628-1634.
    PubMed     Abstract available


  50. KELLER-ROSENTHAL N, Sarig O, Giladi M, Malovitski K, et al
    Pathogenic variants affecting peptidyl arginine deiminase 3 and its major substrates underlie central centrifugal cicatricial alopecia.
    J Invest Dermatol. 2026;146:1596-1604.
    PubMed     Abstract available


  51. ZHANG R, Chen X, Huang H, Huang H, et al
    Beyond depigmentation: A cross-sectional study of 5227 Chinese patients with vitiligo.
    J Invest Dermatol. 2026;146:1571-1577.
    PubMed     Abstract available


  52. PASSERON T, Liu W, Morita A, Goh CL, et al
    Pigmentary Disorders around the World: Self-Reported Prevalence and Impact on QOL and Social Stigmatization.
    J Invest Dermatol. 2026;146:1661-1668.
    PubMed     Abstract available


  53. YANG K, Mircescu A, Okusanya D, Mohsen S, et al
    Understanding the Atopic Dermatitis-Psoriasis Phenotypic Switch Through a Pharmacovigilance-Based Approach.
    J Invest Dermatol. 2026 Jun 1:S0022-202X(26)01267.
    PubMed    


    May 2026
  54. CAUCHETEUX SM, Piguet V
    Langerhans cell-targeted mRNA delivery as a skin-based strategy.
    J Invest Dermatol. 2026 May 30:S0022-202X(26)01191.
    PubMed    


  55. NARAYANA RVL, Lanier AL, Wajapeyee N, Gupta R, et al
    Uveal melanoma: A review of current treatment limitations and the emerging therapeutic potential of natural killer cells.
    J Invest Dermatol. 2026 May 30:S0022-202X(26)01033.
    PubMed     Abstract available


  56. STRATIGOS A, Steinhoff M, Luger T, Tan J, et al
    Impact of atopic dermatitis on education and career choices: the Scars of Life international study.
    J Invest Dermatol. 2026 May 28:S0022-202X(26)01041.
    PubMed    


  57. YAKUPU A, Han C, Wang X
    The periderm in mouse skin development: Evidence for conservation across mammalian species.
    J Invest Dermatol. 2026 May 25:S0022-202X(26)01262.
    PubMed    


  58. DONAHUE LR, Hsu CH, Yang YH, Wong A, et al
    Hmga2-dependent cAMP signaling drives UVB-induced melanocyte stem cell activation.
    J Invest Dermatol. 2026 May 25:S0022-202X(26)01218.
    PubMed     Abstract available


  59. GADDAMEEDHI S, Kemp MG
    When sunlight hits, the skin's clock ticks differently.
    J Invest Dermatol. 2026 May 25:S0022-202X(26)01175.
    PubMed    


  60. ALVES E, Ram R, Mukherjee EM, Gangula R, et al
    Clonal cytotoxic CD8(+) T cell expansion and HLA-B44 supertype association in bupropion-induced severe cutaneous adverse reactions.
    J Invest Dermatol. 2026 May 21:S0022-202X(26)01216.
    PubMed    


  61. STALDER M, Raurich S, Finzel A, Schlifke A, et al
    3-Dimensional Facial Skin Microbiome Mapping: An Integrated Technology for Continuous Visualization of Absolute Microbial Densities.
    J Invest Dermatol. 2026 May 15:S0022-202X(26)01208.
    PubMed    


  62. DEL CASTILLO VELASCO-HERRERA M, Cheema S, Wong K, Billington J, et al
    CARMN fusions and PDGFRB mutations highlight key differences amongst cutaneous tumors with myopericytic differentiation.
    J Invest Dermatol. 2026 May 14:S0022-202X(26)01207.
    PubMed    


  63. ISELIN C, Prompsy P, Tsai YC, Bernard P, et al
    Evaluating T-Cell Clonality In Skin Using a Quantitative TRBC1-Clonality Score.
    J Invest Dermatol. 2026 May 13:S0022-202X(26)01205.
    PubMed     Abstract available


  64. SAHU A, Gill M, Hermawan A, Shinde A, et al
    PARP1 as a biomarker for differentiating melanoma from benign melanocytic lesions.
    J Invest Dermatol. 2026 May 12:S0022-202X(26)01198.
    PubMed    


  65. AYE SM, Chew C, Keys P, Griffiths CEM, et al
    Skin care without borders: A UK-Myanmar teledermatology initiative.
    J Invest Dermatol. 2026 May 12:S0022-202X(26)01203.
    PubMed    


  66. ALDIEN AS, McMullen E, Huang C, Granville DJ, et al
    Skin in the claim: United States patenting process and tips for dermatologists.
    J Invest Dermatol. 2026 May 12:S0022-202X(26)01027.
    PubMed    


  67. ORO AE, Amagai M, Payne AS, Ellebrecht C, et al
    Mechanistic insights into emerging therapeutic platforms: The 72(nd) annual Montagna Symposium on the biology of skin.
    J Invest Dermatol. 2026 May 7:S0022-202X(26)01016.
    PubMed    


  68. CHEN R, Miltner LA, Loman L, Schuttelaar MLA, et al
    ADULTS WITH ATOPIC DERMATITIS AND ATOPIC MULTIMORBIDITY EXPERIENCE IMPAIRED SLEEP QUALITY.
    J Invest Dermatol. 2026 May 7:S0022-202X(26)01188.
    PubMed    


  69. JAYASINGHE D, Torrano J, Betz-Stablein B, Janda M, et al
    Nevus clustering on the back associated with in situ melanoma in a Queensland melanoma high-risk cohort.
    J Invest Dermatol. 2026 May 6:S0022-202X(26)01186.
    PubMed    


  70. SERRANO PONS J, Romero-Lopez A, Munoz I, Carrion C, et al
    The World Health Organization Skin Neglected Tropical Diseases App: A dynamic capacity building training tool enhanced with artificial intelligence.
    J Invest Dermatol. 2026 May 6:S0022-202X(26)01185.
    PubMed     Abstract available


  71. KENT JA, Sacknovitz Y, Fisch SA, Erem SA, et al
    Cutaneous B-Cell Lymphoma Incidence Trends in the United States: A Surveillance, Epidemiology, and End Results Analysis of 10,975 Cases.
    J Invest Dermatol. 2026 May 4:S0022-202X(26)01178.
    PubMed    


  72. MERKUS VA, IJsselsteijn ME, de Jong E, Tensen CP, et al
    Spatial immune profiling characterizes tumor microenvironment heterogeneity between metastatic and non-metastatic cutaneous squamous cell carcinoma in organ transplant patients.
    J Invest Dermatol. 2026 May 4:S0022-202X(26)01181.
    PubMed    


  73. WOLLAM J, Solomon M, Villescaz C, Srinivasan S, et al
    MRGPRX2 Antagonist Treatment Prevents Inflammation and Disease in a Mouse Model of Atopic Dermatitis.
    J Invest Dermatol. 2026 May 4:S0022-202X(26)01182.
    PubMed     Abstract available


  74. PRYOR Y, He J, Kang J, Jenkins B, et al
    Optical limits in skin reflectance measurement: Quantifying melanin-dependent constraints on erythema detection.
    J Invest Dermatol. 2026 May 4:S0022-202X(26)01014.
    PubMed     Abstract available


  75. CHEN ZT, Cui MJ, Guo SK, Wang ZL, et al
    Single-Cell RNA Sequencing Reveals Bidirectional Development of Infantile Hemangioma.
    J Invest Dermatol. 2026;146:1344-1353.
    PubMed     Abstract available


  76. HAO J, Chu M, Ma J, Xu G, et al
    Integrative Mendelian Randomization and Transcriptomic Analysis Reveal the Causal Association between Psoriatic Arthritis and Uveitis.
    J Invest Dermatol. 2026;146:1256-1264.
    PubMed     Abstract available


  77. MARTIN A, Shokrian N, Kelley KJ, Correa da Rosa J, et al
    Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia.
    J Invest Dermatol. 2026;146:1265-1270.
    PubMed     Abstract available


    April 2026
  78. GELFAND JM, Li AZ, Song WB, Ghonim M, et al
    The effect of apremilast on epicardial adipose tissue in psoriasis.
    J Invest Dermatol. 2026 Apr 29:S0022-202X(26)01166.
    PubMed    


  79. BATZORIG U, Zhang G, Yang CC, Liu Y, et al
    ZNF750 safeguards upper hair follicle homeostasis to prevent inflammatory skin disease.
    J Invest Dermatol. 2026 Apr 29:S0022-202X(26)01167.
    PubMed    


  80. BOOSTANI M, Siegel AP, Eathara A, Kiss N, et al
    Skin imaging techniques for melanoma detection: A scoping review of modalities, clinical viability, and deployment strategies.
    J Invest Dermatol. 2026 Apr 24:S0022-202X(26)00754.
    PubMed     Abstract available


  81. SLAPE D, McMeniman E, Kong K
    Creating equitable pathways to close the gap in dermatology workforce representation and skin health for Indigenous Australians.
    J Invest Dermatol. 2026 Apr 21:S0022-202X(26)00964.
    PubMed    


  82. WITTE F, Wiegmann H, Teitge E, Westmeier J, et al
    Evaluation of Itch Intensity Scales in Atopic Dermatitis: Differential Measurement Properties and Associations with Relevant Cytokines.
    J Invest Dermatol. 2026 Apr 20:S0022-202X(26)01046.
    PubMed     Abstract available


  83. BEHLOCK Y, Gavan SP, Graier T, Guevara BE, et al
    The role of biosimilars in enhancing global access to psoriasis treatment.
    J Invest Dermatol. 2026 Apr 17:S0022-202X(26)01044.
    PubMed     Abstract available


  84. MARTZLOFF P, Testroet F, Salatino A, Ahmed A, et al
    Mast cell homeostasis depends on KIT ligand from dermal fibroblasts and perivascular cells in mouse skin.
    J Invest Dermatol. 2026 Apr 13:S0022-202X(26)01023.
    PubMed     Abstract available


  85. YOULDEN DR, Atkinson V, Pinkham MB, Barbour A, et al
    Second primary invasive cutaneous melanomas in Queensland over 4 decades.
    J Invest Dermatol. 2026 Apr 7:S0022-202X(26)00075.
    PubMed     Abstract available


  86. HAYKAL D, Flament F
    Intelligent mirrors for longitudinal skin phenotyping.
    J Invest Dermatol. 2026 Apr 3:S0022-202X(26)00745.
    PubMed    


  87. RUJITHARANAWONG C, Werth VP, Payne AS
    Boom or Bust: Clinical Trials in Pemphigus and Other B-Cell-Mediated Autoimmune Diseases.
    J Invest Dermatol. 2026;146:914-920.
    PubMed     Abstract available


  88. PEREIRA MP, Butze M, Vera Ayala C, Kolkhir P, et al
    The Role of Mast Cells in the Pathophysiology of Chronic Prurigo.
    J Invest Dermatol. 2026;146:921-929.
    PubMed     Abstract available


  89. HUANG J, Hu Y, Zhang Y, Jiang L, et al
    Integrating Multiomic Mendelian Randomization, Microarray, Single-Cell RNA Sequencing, and Spatial RNA Sequencing to Identify Potential Therapeutic Targets for Vitiligo.
    J Invest Dermatol. 2026;146:998-1010.
    PubMed     Abstract available


  90. VAN DEN HEUVEL A, Wondergem AP, Kim M, Breet I, et al
    A Splicing Variant in XPA Results in Delayed Onset of Clinical Features of Xeroderma Pigmentosum.
    J Invest Dermatol. 2026;146:1102-1114.
    PubMed     Abstract available


  91. BOUDRA R, Patenall BL, King S, Carter KA, et al
    PRMT1 Inhibition Targets BNC1-Dependent Proliferation in Squamous Cell Carcinoma.
    J Invest Dermatol. 2026;146:1011-1027.
    PubMed     Abstract available


  92. ASENSIO A, Sanz-Flores M, Liakath-Ali K, Romo-Gallo A, et al
    The G-Protein-Coupled Receptor Kinase 2 Orchestrates Hair Follicle Homeostasis.
    J Invest Dermatol. 2026;146:930-953.
    PubMed     Abstract available


  93. MARSCHALL J, Schierhofer LIA, Santos AMS, Hinterseher J, et al
    Deep Analysis of Desmoglein-3-Reactive CD4(+) T Cells in Pemphigus Vulgaris Reveals a Type 17/Type 2 T-Cell Signature.
    J Invest Dermatol. 2026;146:973-985.
    PubMed     Abstract available


  94. BRUYERE D, Delahaye T, Nikkels A, Herfs M, et al
    Pathophysiology of cutaneous commensal human papillomaviruses.
    J Invest Dermatol. 2026 Apr 1:S0022-202X(26)00133.
    PubMed     Abstract available


    March 2026
  95. MAGNE B, Cattier B, Lemire-Rondeau M, Morissette A, et al
    DE NOVO FORMATION OF HUMAN SEBACEOUS GLANDS USING SELF-ASSEMBLED SKIN SUBSTITUTES.
    J Invest Dermatol. 2026 Mar 31:S0022-202X(26)01010.
    PubMed     Abstract available


  96. XU J, Haulrig MB, Andersson AM, Lwin SM, et al
    Psoriasis in Greenland: A Global Psoriasis Atlas Population-Based Study in Tasiilaq, East Greenland.
    J Invest Dermatol. 2026 Mar 27:S0022-202X(26)01004.
    PubMed    


  97. CHUPRIN J, Lopes CS, MingJie Gao K, Chiang K, et al
    Endothelial cell expression of STING(V154M) gain-of-function mutation delays the resolution of UVB-induced skin injury.
    J Invest Dermatol. 2026 Mar 27:S0022-202X(26)01003.
    PubMed     Abstract available


  98. TRUJILLO A, Munguia N, Craig N, Wilkes R, et al
    Genome-wide Study Identifies a Locus Associated with Atopic Dermatitis Severity in a Canine Model.
    J Invest Dermatol. 2026 Mar 25:S0022-202X(26)01000.
    PubMed    


  99. PONCE MB, Heaton AR, Burkard SK, D'Amato A, et al
    Atovaquone-induced therapeutic rewiring of melanoma metabolism.
    J Invest Dermatol. 2026 Mar 23:S0022-202X(26)00969.
    PubMed    


  100. PRINZ JC
    The HLA-C *06:02-presented skin immunopeptidome: A valuable resource for unravelling the autoimmune pathogenesis of psoriasis.
    J Invest Dermatol. 2026 Mar 18:S0022-202X(26)00063.
    PubMed    


  101. CHEN YH, Liau JY, Tsai JF, Liao YH, et al
    Spatial Lipidomics-based Melanoma Diagnostics by Integration of Mass Spectrometry Imaging and Machine Learning.
    J Invest Dermatol. 2026 Mar 17:S0022-202X(26)00963.
    PubMed     Abstract available


  102. ZHAN Y, Dahabieh MS, Rajakumar A, Dobocan MC, et al
    Corrigendum to 'The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma': [Journal of Investigative Dermatology, Volume 135, Issue 5, May 2015, Pages 1368-1376].
    J Invest Dermatol. 2026 Mar 13:S0022-202X(25)03516.
    PubMed    


  103. OLIVARES-GUERRERO M, Gonzalez-Quesada A, Sahuquillo-Torralba A, Rivera-Diaz R, et al
    Risk of infections in patients with psoriasis treated with biologic agents and new oral small molecules. BIOBADADERM Registry.
    J Invest Dermatol. 2026 Mar 11:S0022-202X(26)00753.
    PubMed     Abstract available


  104. JIANG W, Xie X, Yang S, Xu R, et al
    Basophil Activity in Atopic Dermatitis: Distinct Immunomodulatory Roles of Dupilumab and Abrocitinib.
    J Invest Dermatol. 2026 Mar 9:S0022-202X(26)00746.
    PubMed     Abstract available


  105. SHAH K, Verma P, Hamil T, Dey P, et al
    Nintedanib Attenuates Profibrotic Gene Expression in a 3D Organotypic Culture Model of Systemic Sclerosis Skin Fibrosis.
    J Invest Dermatol. 2026 Mar 6:S0022-202X(26)00742.
    PubMed    


  106. JIA W, Katta N, Kennedy GT, Lee J, et al
    Optical and acoustic scattering in cutaneous neurofibromas: Implications for early detection.
    J Invest Dermatol. 2026 Mar 6:S0022-202X(26)00741.
    PubMed     Abstract available


  107. ISHIKAWA M, Ngo YX, Nishikawa I, Kato H, et al
    Spatial organization of epithelial heterogeneity through undulating structures of the skin and oral mucosa.
    J Invest Dermatol. 2026 Mar 3:S0022-202X(26)00138.
    PubMed     Abstract available


  108. OTROFANOWEI E, Ahogo KC, Atadokpede F, Bahloul E, et al
    Accessibility And Affordability Of Emollients In The Management Of Atopic Dermatitis (AD) In Africa.
    J Invest Dermatol. 2026 Mar 2:S0022-202X(26)00137.
    PubMed     Abstract available


  109. RENTROIA-PACHECO B, Steijlen OFM, Bellomo D, van Keulen D, et al
    Nested Case-Control and Case-Cohort: Efficient Study Designs to Develop Biomarker-Based Prediction Models for Rare Outcomes.
    J Invest Dermatol. 2026;146:591-601.
    PubMed     Abstract available


  110. BRINKS AL, Needle CD, Perez OD, Shapiro J, et al
    The Polygenic Architecture of Human Diseases Affecting the Hair Follicle.
    J Invest Dermatol. 2026;146:602-612.
    PubMed     Abstract available


  111. ZHU Y, Zhao C, Yan H, Lu M, et al
    Multiomics Mendelian Randomization Reveals Causal Oxidative Stress Genes in Androgenetic Alopecia.
    J Invest Dermatol. 2026;146:654-668.
    PubMed     Abstract available


  112. OUWERKERK W, Narayan VS, Chielie S, van Uden NOP, et al
    Immune and Biological Changes during Treatment in Patients with Nonsegmental Vitiligo and their Relation to Repigmentation.
    J Invest Dermatol. 2026;146:699-710.
    PubMed     Abstract available


  113. ANSARI AW, Habib T, Ahmad F, Raheed T, et al
    Cathelicidin LL-37-Induced Transcriptome of Human Keratinocyte Identifies Chemokine CXCL10 Link to T-Cell-Mediated Rosacea Pathogenesis through Jak1/STAT1 Pathway.
    J Invest Dermatol. 2026;146:711-721.
    PubMed     Abstract available


    February 2026
  114. GLASS DA 2ND, Horsley V, Liu Y, Plikus MV, et al
    Decoding Keloids: Single-Cell Heterogeneity, Emerging Role of Adipocytes, Molecular Biomarkers, and Therapeutic Implications in Skin of Color.
    J Invest Dermatol. 2026 Feb 28:S0022-202X(26)00139.
    PubMed     Abstract available


  115. HAYKAL D
    Haptic skin intelligence: Digitizing cutaneous mechanics for investigative dermatology.
    J Invest Dermatol. 2026 Feb 26:S0022-202X(26)00066.
    PubMed    


  116. ZHENG YX, Zheng M
    'Thousand counties, no psoriasis': A public-health pathway to early psoriasis care in China.
    J Invest Dermatol. 2026 Feb 26:S0022-202X(26)00036.
    PubMed    


  117. JOHANSSON PA, Palmer JM, Brooks KM, Chan HH, et al
    Genetic architecture of multiple primary cutaneous melanoma in the absence of high-penetrance susceptibility genes.
    J Invest Dermatol. 2026 Feb 26:S0022-202X(26)00134.
    PubMed     Abstract available


  118. KUMAR R, Calderon Alonso AI, Ji Z, Njauw CN, et al
    Differential stability of NRAS and BRAF oncoproteins in melanoma.
    J Invest Dermatol. 2026 Feb 26:S0022-202X(26)00131.
    PubMed    


  119. LUO Y, Bal AB, Balagula Y, Garshick M, et al
    Impact of deucravacitinib on NLR and other inflammatory biomarkers of cardiovascular risk in psoriasis: post hoc analyses of phase 3 trials.
    J Invest Dermatol. 2026 Feb 24:S0022-202X(26)00130.
    PubMed    


  120. XU Y, Lu L, Liu P, Wang Y, et al
    Blue Light Irradiation Induces Skin Barrier Damage via EGFR/ERK/c-Jun Signaling Pathway.
    J Invest Dermatol. 2026 Feb 23:S0022-202X(26)00102.
    PubMed    


  121. MCBRIDE JD
    Endothelial cell-derived extracellular vesicles: Newly recognized instruments in the symphony of skin repair.
    J Invest Dermatol. 2026 Feb 23:S0022-202X(26)00011.
    PubMed    


  122. SLOMINSKI AT, Tuckey RC, Slominski RM, Holick MF, et al
    On the role of cholesterol, vitamin D, lumisterol, and tachysterol signaling in psoriasis.
    J Invest Dermatol. 2026 Feb 20:S0022-202X(26)00021.
    PubMed    


  123. LIU Y, Zeng X, Huang S, Jin Y, et al
    CD68 Identified as a Regulator of Human Melanocyte Development and Function.
    J Invest Dermatol. 2026 Feb 19:S0022-202X(26)00096.
    PubMed     Abstract available


  124. HUANG C, Kumar M, Yan L, Xiong N, et al
    CCL27 regulates immune responses and angiogenesis in skin wound healing process.
    J Invest Dermatol. 2026 Feb 19:S0022-202X(26)00098.
    PubMed    


  125. TANG AS, Wei ML, Haemel A, La C, et al
    artificial intelligence-enabled precision medicine for inflammatory skin diseases.
    J Invest Dermatol. 2026 Feb 13:S0022-202X(25)03518.
    PubMed     Abstract available


  126. KOKKONEN N, Varpuluoma O, Tuusa J, Pylkas K, et al
    Genes associated with immune response are upregulated in clinically healthy skin of patients with gliptin-associated bullous pemphigoid.
    J Invest Dermatol. 2026 Feb 12:S0022-202X(26)00085.
    PubMed    


  127. IRIE H, Nakashima C, Ishida Y, Kitayama N, et al
    A peripheral neurons-basophil axis drives heat-killed Staphylococcus aureus-induced dermatitis via TLR2 signaling pathway.
    J Invest Dermatol. 2026 Feb 12:S0022-202X(26)00083.
    PubMed    


  128. LI C, Mullan KA, Ye J, Burns FA, et al
    Spatial insights into psoriasis: A single cell transcriptomics pipeline to study inflammatory skin disease.
    J Invest Dermatol. 2026 Feb 12:S0022-202X(26)00086.
    PubMed    


  129. SONG I, Blumberg MA, Kam CY
    Live imaging of vascular dynamics in mouse skin.
    J Invest Dermatol. 2026 Feb 12:S0022-202X(26)00024.
    PubMed     Abstract available


  130. RIZO-POTAU D, Fornies-Marine A, Villanueva-Canas JL, Aguilar M, et al
    Exploring global cfDNA fragmentomics as a biomarker in real-world melanoma patients.
    J Invest Dermatol. 2026 Feb 6:S0022-202X(26)00079.
    PubMed     Abstract available


  131. CELAC I, Nguyen BT, Larouche D, Mainville L, et al
    Reevaluating the Declaration of Sex in Skin Cell Studies.
    J Invest Dermatol. 2026 Feb 5:S0022-202X(26)00077.
    PubMed    


  132. XIAO F, Wu R, Wu N, Xie Y, et al
    Fat mass and obesity-associated (FTO)/SOCS6-m(6)A axis epigenetic modification links obesity to atopic dermatitis by regulating keratinocyte function.
    J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00068.
    PubMed     Abstract available


  133. RAWAL D, Lee WJ, Shim WS
    Azelaic acid potentiates TRPV3 activity as a mechanism for skin irritation.
    J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00071.
    PubMed    


  134. DI GIROLAMO D, Di Cicco E, Miro C, Murolo M, et al
    Thyroid hormone inactivation sustains cancer stem cell maintenance and tumorigenesis in basal cell carcinoma.
    J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00074.
    PubMed     Abstract available


  135. SIMPSON CL
    Leveraging gene-edited cells in organotypic models to discover therapeutic strategies for orphan skin diseases.
    J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00072.
    PubMed    


  136. WANG Q, Roh E, Khan AU, Dickinson SE, et al
    Deletion of p53-Related Protein Kinase Suppresses Solar UV-Induced Photocarcinogenesis by Inhibiting PD-L1 Expression and Enhancing CD8 T-Cell Infiltration.
    J Invest Dermatol. 2026;146:405-417.
    PubMed     Abstract available


  137. BELPAIRE A, Demeyer A, Berrevoet D, Van Nieuwerburgh F, et al
    Downregulated Aryl Hydrocarbon Receptor Expression Is Linked with Increased IFN-gamma Production and Impaired Immune Checkpoint Upregulation in Vitiligo.
    J Invest Dermatol. 2026;146:393-404.
    PubMed     Abstract available


  138. OKAMURA K, Arai Y, Kawaguchi J, Tsukada S, et al
    A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation.
    J Invest Dermatol. 2026;146:374-382.
    PubMed     Abstract available


  139. KHAN SG, Baghoomian W, Kuschal-Tauzon C, Tamura D, et al
    RNA Lariat-Debranching Enzyme (DBR1) Variations in Sabinas Brittle Hair Syndrome Form of Trichothiodystrophy: A Trichothiodystrophy-Causing Gene.
    J Invest Dermatol. 2026;146:432-441.
    PubMed     Abstract available


    January 2026
  140. KAWAI T, Hayashi R, Hasegawa A, Sato H, et al
    Pre-eradication fecal Helicobacter pylori antigen levels as a predictive marker for skin eruption during eradication therapy.
    J Invest Dermatol. 2026 Jan 23:S0022-202X(26)00031.
    PubMed    


  141. XIE F, Xie Y, Liu J
    Botulinum Neurotoxin Type A1 Alleviates Bleomycin-induced Skin Fibrosis by Inhibiting PI3K-Akt Pathway and Associated Cell Cycle and Proliferation.
    J Invest Dermatol. 2026 Jan 23:S0022-202X(26)00030.
    PubMed     Abstract available


  142. DUBRAC S, Combarros D, Olah A, Cadiergues MC, et al
    Recommendations on in vitro models for canine atopic dermatitis.
    J Invest Dermatol. 2026 Jan 20:S0022-202X(25)03668.
    PubMed    


  143. XING X, Ren J, Zhu Y, Lin Y, et al
    HSP70/TLR2 Orchestrates Melanocyte Ferroptosis in the Onset of Vitiligo.
    J Invest Dermatol. 2026 Jan 14:S0022-202X(26)00009.
    PubMed     Abstract available


  144. KHALIL N, Edwards E, Yosipovitch G
    Scratch and tickle: Divergent cutaneous sensations with common neurobiological roots.
    J Invest Dermatol. 2026 Jan 9:S0022-202X(25)03615.
    PubMed     Abstract available


  145. ZOU Y, Nusken M, Liao K, Hahn KK, et al
    The multifaceted roles of oncostatin M and its receptor in skin immunity, inflammation, and tumorigenesis.
    J Invest Dermatol. 2026 Jan 8:S0022-202X(25)03632.
    PubMed     Abstract available


  146. MARELLA S, Plikus M, Gudjonsson JE
    Skin fibroblasts in health and disease: From extracellular matrix remodeling to immune regulation.
    J Invest Dermatol. 2026 Jan 5:S0022-202X(25)03638.
    PubMed     Abstract available


  147. STROTHER C, Bouffard N, Smolynets O, Graham NR, et al
    Corrigendum to 'Localized Inflammation in Dengue Vaccine-Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome' Journal of Investigative Dermatology Volume 145, Issue 8, August 2025, Pages 2021-2033.e3.
    J Invest Dermatol. 2026 Jan 3:S0022-202X(25)03498.
    PubMed    


  148. ROSEN N, Holling T, Junod I, Alawi M, et al
    KREMEN1 Variants Associated with Ectodermal Dysplasia Impair Complex Formation of KREMEN1 with DKK1 and LRP6 and Attenuate WNT3A Response.
    J Invest Dermatol. 2026;146:139-150.
    PubMed     Abstract available


  149. CRISLER WJ, Rowley R, Oke O, Steuart SJ, et al
    Eosinophilic Fasciitis and Morphea Share Gene Signatures of Inflammatory Cell Death, Self-DNA Recognition, and Enhanced Jak/Signal Transducer and Activator of Transcription Signaling.
    J Invest Dermatol. 2026;146:64-77.
    PubMed     Abstract available


  150. SHAFIUDDIN M, Huang WC, Prather GW, Anton JR, et al
    Cutibacterium Adaptation to Life on Humans Provides a Potential C acnes Infection Biomarker.
    J Invest Dermatol. 2026;146:198-213.
    PubMed     Abstract available


  151. QUAN K, Yang Y, Li C, Yao X, et al
    Single-Cell RNA Sequencing + TCR Sequencing Reveal the Proportion and Characteristics of Dual TCR T Cells in Tertiary Lymphoid Structures in Pemphigus.
    J Invest Dermatol. 2026;146:78-90.
    PubMed     Abstract available


  152. FISCHER B, Kolb A, Focaccia E, Kubelbeck T, et al
    NOD2-Induced IkappaBzeta Mediates a Protective Host Response against Epicutaneous Staphylococcus aureus Infection.
    J Invest Dermatol. 2026;146:184-197.
    PubMed     Abstract available


  153. SPENCER RH, Kilfeather SA, Lee E, Munera C, et al
    Systemic Inflammatory Markers Correlate with Chronic Kidney Disease-Associated Pruritus and Response to Treatment.
    J Invest Dermatol. 2026;146:175-183.
    PubMed     Abstract available


    December 2025
  154. BRAUN A, Mobbs JI, Chung S, Tuomisto JE, et al
    A transgenic mouse allows characterisation of the HLA-C*06:02 immunopeptidome in a model of psoriasis.
    J Invest Dermatol. 2025 Dec 24:S0022-202X(25)03684.
    PubMed     Abstract available


  155. LARUE L
    E-Cadherin, MITF, and Phenotypic Plasticity in Melanoma: A Crossroads between Cell Adhesion, Differentiation, and Hormonal Regulation.
    J Invest Dermatol. 2025 Dec 19:S0022-202X(25)03623.
    PubMed    


  156. ZHOU J, Lan Y, Gong X, Qiu T, et al
    PPARG promotes kaposiform hemangioendothelioma progression via the CD36-mediated lipid metabolic pathway.
    J Invest Dermatol. 2025 Dec 18:S0022-202X(25)03676.
    PubMed    


  157. AN J, Bogle R, Najjar R, Tsoi LC, et al
    Single Cell and Spatial Transcriptomics Implicate Vascular Cell Orchestration of Inflammatory Changes After Ultraviolet Light Exposure in Skin.
    J Invest Dermatol. 2025 Dec 17:S0022-202X(25)03673.
    PubMed     Abstract available


  158. AGUGLIA R, Assouline M, Van Dieren L, Berkane Y, et al
    AI-Enhanced Dermoscopy for Early Skin Cancer Detection in Private Practice: Insights from a Retrospective Cohort Study.
    J Invest Dermatol. 2025 Dec 17:S0022-202X(25)03672.
    PubMed    


  159. PASSERON T, Regazzetti C, Menigot C, Sircoulomb F, et al
    Histological and transcriptomic comparative analysis of skin response to ultraviolet radiation in the scalp compared to the forearms.
    J Invest Dermatol. 2025 Dec 17:S0022-202X(25)03674.
    PubMed    


  160. ELIAS PM
    Ultraviolet Light and the Barrier Comments on J. Gu and R. Weller: "Suberythemal Sun and the Skin," JID 145: 2122-2124, 2025.
    J Invest Dermatol. 2025 Dec 16:S0022-202X(25)03670.
    PubMed    


  161. DEWEY EJ, Feldman SR, Mostaghimi A
    Barriers to comparison of relative remission rates of systemic therapies for moderate-to-severe plaque psoriasis.
    J Invest Dermatol. 2025 Dec 16:S0022-202X(25)03667.
    PubMed    


  162. TISON A, Legoupil D, Le Rochais M, Hemon P, et al
    B-cell involvement in immune checkpoint inhibitor-induced lichen planus: a comparative analysis with non-drug-related lichen planus.
    J Invest Dermatol. 2025 Dec 15:S0022-202X(25)03639.
    PubMed    


  163. KIM KC, Lee JH
    Harnessing cannabidiol: an approach to attenuating Th2 inflammation via JAK/STAT signaling and modulating CB2 receptor in atopic dermatitis.
    J Invest Dermatol. 2025 Dec 15:S0022-202X(25)03640.
    PubMed    


  164. CHOUDHURY A, Garcet S, Cueto I, Kunjravia N, et al
    Molecular, Histological, and Clinical Effects of Selective TYK2 Inhibition with Zasocitinib (TAK-279) in Patients with Moderate-to-Severe Plaque Psoriasis.
    J Invest Dermatol. 2025 Dec 10:S0022-202X(25)03625.
    PubMed    


  165. NEEDLE CD, Brinks AL, Perez OD, Shapiro J, et al
    A Comprehensive Review of GWASs of Human Hair Traits.
    J Invest Dermatol. 2025;145:2964-2972.
    PubMed     Abstract available


  166. QIU X, Feng Y, Mo X, Ju Q, et al
    Multi-Omics Analysis Identifies Genetic Mechanisms and Therapeutic Targets for Acne Vulgaris.
    J Invest Dermatol. 2025;145:3037-3050.
    PubMed     Abstract available


  167. LUKAS D, Liu X, Reibetanz M, Konen-Waisman S, et al
    Innate Lymphoid Cell 1- and NK Cell-Derived, Early IFNg Release Depends on ICER and Promotes Protection against Leishmania major Infection.
    J Invest Dermatol. 2025;145:3138-3144.
    PubMed     Abstract available


  168. QIN M, Evron E, Tran PT, Deng M, et al
    Immune Activation and Glycolytic Responses to Cutibacterium acnes Cell Wall Polysaccharides.
    J Invest Dermatol. 2025;145:3126-3137.
    PubMed     Abstract available


  169. TOBIAS R, Kumar S, Liu J, Lenci N, et al
    Unrestrained MyD88 Signaling in A20-Deficient Keratinocytes Triggers T-Cell-Dependent Psoriatic Arthritis-Like Disease.
    J Invest Dermatol. 2025;145:2998-3010.
    PubMed     Abstract available


  170. WU CY, Vadhan A, Wei WY, Yu HS, et al
    Luteinizing Hormone Induces Murine Hair Loss through Transient Receptor Potential Canonical Channel-Mediated Cell Aging Responses: Implications for Female Pattern Hair Loss Pathogenesis.
    J Invest Dermatol. 2025;145:2989-2997.
    PubMed     Abstract available


    November 2025
  171. LOPES PO, Fantecelle CH, Barboza BA, Freire-de-Lima CG, et al
    Spatial Profiling of Human Diffuse Cutaneous Leishmaniasis Lesions Reveals Immunosuppressive Microenvironments that Coincide with Parasite Localisation.
    J Invest Dermatol. 2025 Nov 27:S0022-202X(25)03610.
    PubMed    


  172. RAJA DAVID ISAC EB, Sigurbjornsdottir S, Dilshat R, Cornell RA, et al
    Phenotype switching in melanoma cells: MITF regulates the expression of CDH1 through E-boxes in an intronic region.
    J Invest Dermatol. 2025 Nov 26:S0022-202X(25)03605.
    PubMed     Abstract available


  173. DASGUPTA R, Park PH, Wallace M, Marzula V, et al
    A CD206 targeting peptide exhibits preclinical therapeutic efficacy in cutaneous T-cell lymphoma.
    J Invest Dermatol. 2025 Nov 26:S0022-202X(25)03607.
    PubMed    


  174. VAN EE A, Garza LA
    New Insights into the Neglected Disease Vulvar Lichen Sclerosus.
    J Invest Dermatol. 2025 Nov 21:S0022-202X(25)03416.
    PubMed    


  175. LAN J, Jiang B, Zhang X, Xia Y, et al
    CD36-mediated long-chain fatty acids transport in keratinocytes promotes psoriasis-like skin inflammation through increasing mitochondrial reactive oxygen species.
    J Invest Dermatol. 2025 Nov 20:S0022-202X(25)03555.
    PubMed     Abstract available


  176. TORRADO B, Vallmitjana A, Ranjit S, Far-Hadian M, et al
    In Vivo Human Skin Imaging: Distinguishing Cellular and Fibrillar Components with Fluorescence Lifetime Microscopy.
    J Invest Dermatol. 2025 Nov 18:S0022-202X(25)03549.
    PubMed    


  177. BISSONNETTE R, Saint-Cyr Proulx E, Correa da Rosa J, Estrada Y, et al
    Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers.
    J Invest Dermatol. 2025 Nov 18:S0022-202X(25)03550.
    PubMed     Abstract available


  178. WONG SY, Harms PW, Dlugosz AA
    Does Basal Cell Carcinoma Arise from a Precursor Lesion?
    J Invest Dermatol. 2025 Nov 15:S0022-202X(25)03417.
    PubMed     Abstract available


  179. BAPNA M, Karn EE, Lotter W, Ruiz ES, et al
    Comparative Analysis of Staging and Metastatic Risk Stratification Systems for Cutaneous Squamous Cell Carcinoma.
    J Invest Dermatol. 2025 Nov 14:S0022-202X(25)03545.
    PubMed    


  180. BALOGH F, Magyari A, Erdei L, Bolla BS, et al
    Cutibacterium acnes induces skin region-specific innate immune memory alterations in human keratinocytes.
    J Invest Dermatol. 2025 Nov 14:S0022-202X(25)03544.
    PubMed     Abstract available


  181. HOLLSTEIN MM, Nusken M, Hahn KK, Mewes KR, et al
    Generating Immunocompetent 3-Dimensional Full-Thickness Models of Human Skin.
    J Invest Dermatol. 2025 Nov 12:S0022-202X(25)03514.
    PubMed     Abstract available


  182. AMECHI C, Shakiba S, Rookey AK, James N, et al
    Spatial transcriptomics and proteomics of mycosis fungoides biopsies from skin of color patients reveal biomarkers and potential treatment targets.
    J Invest Dermatol. 2025 Nov 12:S0022-202X(25)03533.
    PubMed    


  183. NALDI L, Mercuri SR
    Early Childhood Stress and the Risk of Psoriasis: What Next?
    J Invest Dermatol. 2025 Nov 11:S0022-202X(25)03457.
    PubMed    


  184. KAWAKAMI E
    Dynamic Network Biomarker Analysis Reveals Predisease State in Atopic Dermatitis.
    J Invest Dermatol. 2025 Nov 11:S0022-202X(25)03458.
    PubMed    


  185. MIER-AGUILAR CA, Sherwani MA, Tsuruta Y, Abdelsamad N, et al
    Identification of UVB-induced TREM-1 positive tolerogenic DCs and TREM-1 signaling as a target in the prevention of UVB-induced immune suppression and skin carcinogenesis.
    J Invest Dermatol. 2025 Nov 7:S0022-202X(25)03526.
    PubMed     Abstract available


  186. ZHOU T, Feng Y, Che D, Yan C, et al
    MRGPRX2-Mediated Mast Cell Activation Promotes Malignant Progression of Cutaneous Squamous Cell Carcinoma via IL-17A Release.
    J Invest Dermatol. 2025 Nov 4:S0022-202X(25)03517.
    PubMed     Abstract available


  187. BRAUN FK, Hirsch B, Al-Yacoub N, Durkop H, et al
    Corrigendum to 'Resistance of Cutaneous Anaplastic Large-Cell Lymphoma Cells to Apoptosis by Death Ligands Is Enhanced by CD30-Mediated Overexpression of c-FLIP': Journal of Investigative Dermatology, Volume 130, Issue 3, March 2010, Pages 826-840.
    J Invest Dermatol. 2025 Nov 3:S0022-202X(25)02829.
    PubMed    


  188. PARK JJ, Richards D, Tseng PH, Ebata T, et al
    Methods to Validate Digital Health Technologies for Dermatology.
    J Invest Dermatol. 2025;145:2668-2675.
    PubMed     Abstract available


  189. HOFFMAN CL, Shibata Y, Bharathan NK, Helm MF, et al
    Through the Microscope Lens: Investigating the Mechanisms of Desmosome Disruption in Pemphigus.
    J Invest Dermatol. 2025;145:2676-2687.
    PubMed     Abstract available


  190. LV S, Hao Z, Li W, Wei A, et al
    Multiplexed Assays of Variant Effect and Reclassification of TYR Variants in Chinese Patients with Oculocutaneous Albinism.
    J Invest Dermatol. 2025;145:2798-2810.
    PubMed     Abstract available


  191. ZHANG Q, Jang M, Dias FC, Zeng Q, et al
    Neuronal Mechanisms of Psoriatic Itch: Role of IL-17R/ERK/TRPV4 Signaling Pathway.
    J Invest Dermatol. 2025;145:2753-2762.
    PubMed     Abstract available


    October 2025
  192. CHRAYTEH D, Vaulont S, Peyssonnaux C
    Iron-Skin Axis: Exploring the Interplay between Iron Homeostasis and Skin Disorders.
    J Invest Dermatol. 2025 Oct 31:S0022-202X(25)02480.
    PubMed     Abstract available


  193. GEGOTEK A, Wronski A, Zarkovic N, Skrzydlewska E, et al
    Enhanced level of 15-deoxy-12,14-prostaglandin J2-protein adducts in the plasma of patients with psoriasis.
    J Invest Dermatol. 2025 Oct 28:S0022-202X(25)03460.
    PubMed    


  194. HELDER M, Pandeya N, Ingold N, Seviiri M, et al
    Dissecting the genetic architecture of tanning and sunburn as skin cancer risk factors.
    J Invest Dermatol. 2025 Oct 28:S0022-202X(25)03507.
    PubMed     Abstract available


  195. PULLAR JM, Bozonet SM, Segger D, von Seebach A, et al
    Improved human skin vitamin C levels and skin function following dietary intake of kiwifruit - a high vitamin C food.
    J Invest Dermatol. 2025 Oct 28:S0022-202X(25)03509.
    PubMed    


  196. YUAN H, Salapatas AM, Leonardo TR, Han C, et al
    The Role of Endothelial cell-derived Extracellular Vesicles in modulating Fibroblast Function in Skin Wound Healing.
    J Invest Dermatol. 2025 Oct 27:S0022-202X(25)03499.
    PubMed     Abstract available


  197. SMITH CC, Zwerner IM, Gudjonsson JE, Ward NL, et al
    Reevaluating the Imiquimod Model: A Barrier to Translational Progress in Psoriasis.
    J Invest Dermatol. 2025 Oct 27:S0022-202X(25)02429.
    PubMed     Abstract available


  198. HE T, Bergin IL, Kim JY, Guo C, et al
    Fibroblast-Specific Deletion of Tgfbr2 in Mouse Skin Recapitulates Human Skin Dermal Aging by Suppressing Collagen Production.
    J Invest Dermatol. 2025 Oct 21:S0022-202X(25)03418.
    PubMed    


  199. MISERY L, Talagas M, Le Gall-Ianotto C
    Dupilumab's Effects on Itch Sensitization in Atopic Dermatitis.
    J Invest Dermatol. 2025 Oct 21:S0022-202X(25)02477.
    PubMed    


  200. O'REILLY S
    A Long Stretch: IL-11 Drives Skin Regeneration.
    J Invest Dermatol. 2025 Oct 18:S0022-202X(25)02478.
    PubMed    


  201. GHASEMISHAHRESTANI Z, Khumalo NP, Ipp H, Bayat A, et al
    Cutaneous Immune Memory: A Double-Edged Sword in Skin Repair and Fibrosis.
    J Invest Dermatol. 2025 Oct 17:S0022-202X(25)02431.
    PubMed     Abstract available


  202. TURJANMAA E, Kaunisto H, Kemppainen E, Nilsson N, et al
    Dermal IgA is rare in Celiac Disease and relatives, and lacks Dermatitis Herpetiformis-type co-localization with Transglutaminase 3.
    J Invest Dermatol. 2025 Oct 16:S0022-202X(25)03415.
    PubMed    


  203. ZHOU XMM, Williams K, Will E, Jimenez-Sanchez D, et al
    PD-L1 negative macrophages associate with poor outcomes and high grade irAE development in melanoma patients receiving anti-PD-1 immunotherapy.
    J Invest Dermatol. 2025 Oct 16:S0022-202X(25)03414.
    PubMed    


  204. LI H, Chen Y, Su Z, Wang J, et al
    The Role of the Microenvironment on the Localization of Hair and Skin Nonuniform Pigmented Spots in Mice with a Targeted Mutation in the Endothelin B Receptor.
    J Invest Dermatol. 2025 Oct 14:S0022-202X(25)03408.
    PubMed     Abstract available


  205. PEREZ SM, Gherardini J, Vattigunta M, Gomez TG, et al
    Substance P expands proinflammatory, IL-31-secreting M2 macrophages in human skin ex vivo through neurokinin-1 receptor-mediated signaling and increased dermal periostin expression.
    J Invest Dermatol. 2025 Oct 14:S0022-202X(25)03409.
    PubMed    


  206. MIZUNO Y, Umemura M, Nagasako A, Akiyama T, et al
    FAK-Dependent Reprogramming of IFN-gamma Signaling through PYK2 Co-Inhibition Sensitizes Melanoma to Immune Checkpoint Blockade.
    J Invest Dermatol. 2025 Oct 14:S0022-202X(25)03407.
    PubMed     Abstract available


  207. GHEBREHIWET-KUFLOM J, Mehta A, Lim P, Dahle S, et al
    GLP-1 Receptor Agonists as Emerging Modulators of Inflammation and Angiogenesis in Chronic Cutaneous Wound Healing.
    J Invest Dermatol. 2025 Oct 13:S0022-202X(25)02434.
    PubMed     Abstract available


  208. SENAPATI B, Raymundo JR, Makkar J, Driskell RR, et al
    KCTD1/KCTD15-mediated repression of AP-2alpha/AP-2beta is required for proper skin appendage development and epidermal homeostasis.
    J Invest Dermatol. 2025 Oct 9:S0022-202X(25)02832.
    PubMed     Abstract available


  209. PEREZ SM, Kabashima K, Reich K, Gilliet M, et al
    Lessons from TNF-alpha Inhibitor-Induced Alopecia Areata: Does TNF-alpha Operate as a Hair Follicle Immune Privilege Guardian under Inflammatory Conditions?
    J Invest Dermatol. 2025;145:2410-2416.
    PubMed     Abstract available


  210. OLAH P, Reuvers N, Radai Z, Varadi A, et al
    Microbe-Host Interaction in Rosacea and Its Modulation through Topical Ivermectin.
    J Invest Dermatol. 2025;145:2576-2587.
    PubMed     Abstract available


  211. ZHAO Q, Fan Z, Zhang Y, Li J, et al
    Glutamatergic Projections from the Basolateral Amygdala to Medial Prefrontal Cortex Contribute to Acute Itch Sensation Processing.
    J Invest Dermatol. 2025;145:2588-2597.
    PubMed     Abstract available


    September 2025
  212. KLOPFENSTEIN N, Salina A, Blackman A, Aronoff D, et al
    PGE(2)/EP3/CXCR2 axis dictates amplified inflammatory response during skin infection in obese mice.
    J Invest Dermatol. 2025 Sep 30:S0022-202X(25)02476.
    PubMed     Abstract available


  213. OH SW, Yu E, Kwon K, Kim G, et al
    The role of MRGPRX1 in the melanogenesis of human primary epidermal melanocytes.
    J Invest Dermatol. 2025 Sep 29:S0022-202X(25)02475.
    PubMed     Abstract available


  214. ZHANG Y, Huang Y, Jing D, Liang H, et al
    Associations of sleep pattern and genetic risk with late-onset psoriasis: A large prospective cohort study.
    J Invest Dermatol. 2025 Sep 29:S0022-202X(25)02445.
    PubMed     Abstract available


  215. WANG Y, Ward NL
    PPBP/CXCL7: A Novel Chemokine Linking Psoriasis to Atherosclerosis through Endothelial Mitochondrial Dysfunction.
    J Invest Dermatol. 2025 Sep 29:S0022-202X(25)02361.
    PubMed    


  216. GALLO RL, Nakatsuji T, Roso Mares A, Moon J, et al
    Atopic skin resists colonization by beneficial bacteria: A first-in-human analysis of the rate of elimination of topically applied bacteria.
    J Invest Dermatol. 2025 Sep 23:S0022-202X(25)02442.
    PubMed    


  217. SENSUI T, Iwasaki K, Aihara K
    Identification of Pre-Disease State in NC/Nga Mice with Atopic Dermatitis-Like Symptoms Using Dynamical Network Biomarkers.
    J Invest Dermatol. 2025 Sep 22:S0022-202X(25)02436.
    PubMed     Abstract available


  218. VERMA H, Orloff J, Poplausky D, Block B, et al
    Safety, tolerability, and efficacy of topical diphencyprone for cutaneous neurofibromas: results from a phase I clinical trial.
    J Invest Dermatol. 2025 Sep 22:S0022-202X(25)02437.
    PubMed    


  219. SCHNEIDERMAN M
    Association of Adult Atopic Dermatitis and Repetitive Strain Injury: A U.S. Population-Based Study.
    J Invest Dermatol. 2025 Sep 19:S0022-202X(25)02435.
    PubMed    


  220. DUMRONGPHUTTIDECHA T, Ishikawa M, Cabezas-Wallscheid N, Sada A, et al
    Retinoic acid signaling alters the balance of epidermal stem cell populations in the skin.
    J Invest Dermatol. 2025 Sep 18:S0022-202X(25)02433.
    PubMed     Abstract available


  221. XIE J, Zhao S, Wu D, Ma C, et al
    A Metabolism-Driven Prognostic Model and PSMD14-SP1-GYS1 Axis Reveal Therapeutic Vulnerabilities in Melanoma.
    J Invest Dermatol. 2025 Sep 16:S0022-202X(25)02430.
    PubMed     Abstract available


  222. SUN M, Guo P, Guo Q, Li H, et al
    Inducible Nitric Oxide Deficiency Attenuates Necroptosis in Psoriasis-like Dermatitis in Mice through Reducing Oxidative Stress.
    J Invest Dermatol. 2025 Sep 15:S0022-202X(25)02428.
    PubMed     Abstract available


  223. BASH GN, Baghoomian W, Seshadri R, Latour E, et al
    Aberrant Epidermal Innervation in Adults with Atopic Dermatitis is Restored Following Dupilumab Treatment.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02424.
    PubMed    


  224. GALLO RL
    Drugs and Bugs in Atopic Dermatitis: Benefits to the Skin Microbiome from Targeted Immunotherapies.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02325.
    PubMed    


  225. SMITH CJ, Al-Salihi A, Williams JL, Chan L, et al
    Reduced PPOX expression causes intrinsic pathogenicity in keratinocytes, contributing to the cutaneous Variegate Porphyria phenotype.
    J Invest Dermatol. 2025 Sep 9:S0022-202X(25)02418.
    PubMed     Abstract available


  226. WEI J, Wang Y, Chen Y, Wang Z, et al
    Global Burden of Psoriasis from 1990 to 2021 and Potential Factors: A Systematic Analysis.
    J Invest Dermatol. 2025 Sep 8:S0022-202X(25)02415.
    PubMed     Abstract available


  227. DANESH K, Lin FJ, Chen HL, Liu FT, et al
    Galectins in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential.
    J Invest Dermatol. 2025 Sep 8:S0022-202X(25)02330.
    PubMed     Abstract available


  228. BURSHTEIN J, Bunick CG, Vleugels RA, Armstrong AW, et al
    Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy.
    J Invest Dermatol. 2025 Sep 6:S0022-202X(25)02338.
    PubMed    


  229. SAUERLAND MB, Karakaya T, Haulrig MB, Lovendorf MB, et al
    Scalable Acid-Aided Lysis of Skin Samples Improves Proteome Coverage.
    J Invest Dermatol. 2025 Sep 4:S0022-202X(25)02410.
    PubMed     Abstract available


  230. CHOI W, Park DJ, Dorschner RA, Pool K, et al
    Regulated release of small extracellular vesicles directs neutrophil recruitment in cutaneous wound healing.
    J Invest Dermatol. 2025 Sep 4:S0022-202X(25)02411.
    PubMed     Abstract available


  231. KROGH NS, Prieto-Merino D, Coker B, Birkner T, et al
    Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration.
    J Invest Dermatol. 2025 Sep 3:S0022-202X(25)02407.
    PubMed     Abstract available


  232. YUAN H, Sanz NC, Wagner RE, Roessler L, et al
    Skin Explorer: an interactive single-cell RNA-seq resource for healthy human skin.
    J Invest Dermatol. 2025 Sep 2:S0022-202X(25)02399.
    PubMed    


  233. WANG Q, Qiu Q, Sun H, Liu Y, et al
    Distinct Comorbidity Clusters and Their Genetic Associations with Atopic Dermatitis in Middle-Aged and Elderly Adults.
    J Invest Dermatol. 2025 Sep 2:S0022-202X(25)02404.
    PubMed    


  234. CLATCH A, Trubiano JA, James F, Mouhtouris E, et al
    Analysis of skin immune cells in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
    J Invest Dermatol. 2025 Sep 2:S0022-202X(25)02401.
    PubMed     Abstract available


  235. DAS D, Ludvigsson J
    Early childhood stress and the risk of developing psoriasis: a cohort study.
    J Invest Dermatol. 2025 Sep 2:S0022-202X(25)02400.
    PubMed     Abstract available


  236. LONG TJ, Pearson TF, Harris JE
    Deciphering Depigmentation: Mouse Models for Vitiligo Research.
    J Invest Dermatol. 2025;145:2135-2146.
    PubMed     Abstract available


  237. LAI Y, Fan M, Fan X, Chen J, et al
    Progress on Multiomics Research on Acne Vulgaris: A Literature Review.
    J Invest Dermatol. 2025;145:2162-2169.
    PubMed     Abstract available


  238. BAO A, Bordone LA, Aguh C
    A Review of Metabolic Dysregulation in Lymphocytic Cicatricial Alopecia: Exploring the Connections and Therapeutic Implications.
    J Invest Dermatol. 2025;145:2153-2161.
    PubMed     Abstract available


  239. CHOE J, Urbonas R, Xia E, Yan A, et al
    An Assessment of Current Clinician- and Patient-Reported Outcome Measures for Acne Scarring and Dyspigmentation: A Scoping Review.
    J Invest Dermatol. 2025;145:2203-2209.
    PubMed     Abstract available


  240. MUKHATAYEV Z, Kovenskiy A, Ren Z, Rangel SM, et al
    Escherichia Abundance and Metabolism Align with Vitiligo Disease Activity.
    J Invest Dermatol. 2025;145:2236-2250.
    PubMed     Abstract available


  241. MOLTRASIO C, Moura RR, Brandao L, Tricarico PM, et al
    Keratin Variants in Pyoderma Gangrenosum: Pathogenetic Insights from a Whole-Exome Sequencing-Based Bioinformatic Analysis.
    J Invest Dermatol. 2025;145:2229-2235.
    PubMed     Abstract available


  242. WU Y, Liu X, Zhang L, Wang P, et al
    The 5-Aminolevulinic Acid Photodynamic Therapy Modulates Lipid Production by Protein Kinase B/JunD-Mediated NR4A1 Activation in the Treatment of Acne Vulgaris.
    J Invest Dermatol. 2025;145:2179-2190.
    PubMed     Abstract available


  243. HOFFMAN CL, Bharathan NK, Shibata Y, Giang W, et al
    Pemphigus Vulgaris Autoantibodies Induce an Endoplasmic Reticulum Stress Response.
    J Invest Dermatol. 2025;145:2219-2228.
    PubMed     Abstract available


    August 2025
  244. SUN P, Kraus CN, Zhao W, Xu J, et al
    Spatial and single-cell transcriptomics reveal keratinocytes as key players in vulvar lichen sclerosus pathogenesis.
    J Invest Dermatol. 2025 Aug 29:S0022-202X(25)02394.
    PubMed     Abstract available


  245. TANG X, Yang T, Wang J, Bai H, et al
    Profiling of bile acids metabolism in ultraviolet-induced skin injury reveals the protective role of glycodeoxycholic acid and glycochenodeoxycholic acid.
    J Invest Dermatol. 2025 Aug 29:S0022-202X(25)02397.
    PubMed    


  246. ZHU L, Du L, Wu J, Ding D, et al
    Adipose tissue macrophage-derived PPBP exacerbates psoriasis-associated atherosclerosis by inducing mitochondrial dysfunction in aortic endothelial cells.
    J Invest Dermatol. 2025 Aug 29:S0022-202X(25)02396.
    PubMed     Abstract available


  247. DELIC D, Rolser M, Wohnhaas CT, Roy J, et al
    MicroRNA-223 expression during flares in patients with generalized pustular psoriasis is regulated by spesolimab treatment.
    J Invest Dermatol. 2025 Aug 28:S0022-202X(25)02392.
    PubMed    


  248. LAI Y, Jiang Z, Qiu X, Hong D, et al
    Metformin treatment protects mice from glucose-promoted psoriasiform dermatitis through enrichment of Akkermansia muciniphila with modulation of bacterial tryptophan metabolites.
    J Invest Dermatol. 2025 Aug 26:S0022-202X(25)02389.
    PubMed     Abstract available


  249. DONG Y, Sarkar MK, Wu Y, Xing X, et al
    Endothelin-2 from keratinocytes and Its Association with Itch in Skin Diseases.
    J Invest Dermatol. 2025 Aug 22:S0022-202X(25)02354.
    PubMed    


  250. WIEGMANN H, Witte F, Renkhold L, Westmeier J, et al
    Cutaneous neuroanatomical and cellular response to dupilumab treatment in atopic dermatitis.
    J Invest Dermatol. 2025 Aug 22:S0022-202X(25)02353.
    PubMed     Abstract available


  251. LI Y, Zhang W, Teng Y, Zhang X, et al
    High-Resolution Spatial Transcriptomics Unveils Spatially Resolved Gene Modules and Fatty Acid Metabolism Dysregulation in Human Skin Aging.
    J Invest Dermatol. 2025 Aug 22:S0022-202X(25)02352.
    PubMed     Abstract available


  252. YU Z, Chuong CM
    Embryonic Avian Skin Explant Cultures: A Versatile Model for Investigating Tissue Patterning Mechanisms.
    J Invest Dermatol. 2025 Aug 21:S0022-202X(25)02318.
    PubMed     Abstract available


  253. AHMED N, Dawson AD, Anderson ZT, Palmer JW, et al
    Overexpression of NPY leads to progressive, cutaneous inflammatory fibrotic responses in mouse skin.
    J Invest Dermatol. 2025 Aug 20:S0022-202X(25)02347.
    PubMed    


  254. PACULOVA V, Prasad A, Pospisil P
    Oxidative fragmentation of collagen in skin - relevance to skin aging and skin diseases.
    J Invest Dermatol. 2025 Aug 19:S0022-202X(25)02345.
    PubMed    


  255. GIRARDEAU-HUBERT S, Pageon H, Label R, Abdessadeq H, et al
    Exploring the Role of Fibroblast Heterogeneity from Different Skin types in Epidermal Regeneration In Vitro.
    J Invest Dermatol. 2025 Aug 19:S0022-202X(25)02346.
    PubMed     Abstract available


  256. ISHIDA-YAMAMOTO A
    Could Intracellular Transport Systems of Epidermal Lamellar Bodies Be Novel Therapeutic Targets in Skin Diseases?
    J Invest Dermatol. 2025 Aug 19:S0022-202X(25)02261.
    PubMed    


  257. CHAN AA, Noguti J, Ramirez NM, Navarrete M, et al
    Primary Cutaneous Melanoma Microbiome is Associated with Overall Survival and Recurrence.
    J Invest Dermatol. 2025 Aug 18:S0022-202X(25)02342.
    PubMed     Abstract available


  258. PIVARCSI A
    More than Just Nonsense: Long Noncoding RNAs in Cutaneous Squamous Cell Carcinoma.
    J Invest Dermatol. 2025 Aug 18:S0022-202X(25)02271.
    PubMed    


  259. GARCET S, Tsoi LC, Hur H, Blauvelt A, et al
    Comparative molecular analysis of IL-17A and IL-23 pathway inhibition in moderate-to-severe psoriasis: 4-week results from IXORA-R.
    J Invest Dermatol. 2025 Aug 14:S0022-202X(25)02341.
    PubMed     Abstract available


  260. BECKER SL, Bash GN, Begolka WS, Wallace-Hood T, et al
    Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveys.
    J Invest Dermatol. 2025 Aug 13:S0022-202X(25)02337.
    PubMed     Abstract available


  261. DROLL SH, Xue C, Dewar E, Chamberlain N, et al
    Skin Epidermal Progenitor Maintenance by the SRCAP-H2A.Z axis Downstream to ERK and mTOR Signaling.
    J Invest Dermatol. 2025 Aug 12:S0022-202X(25)02333.
    PubMed     Abstract available


  262. LIU Y, Khoong YM, Xia W, Xu R, et al
    Interleukin 11 drives dermal fibroblast activation in mechanical stretch-mediated skin expansion.
    J Invest Dermatol. 2025 Aug 12:S0022-202X(25)02334.
    PubMed     Abstract available


  263. ABBAS AA, Dlova N, Higgins CA
    Beyond the Skin Surface: Melanocyte Biology and the Spectrum of Health Inequities.
    J Invest Dermatol. 2025 Aug 8:S0022-202X(25)02251.
    PubMed     Abstract available


  264. JIANG J, Liu X, Zhang Y, Kong Y, et al
    IL-6 Mediated Neurogenic Inflammation Regulated by the DRG Macrophages Exacerbates Imiquimod-Induced Psoriasis-Like Skin Lesions in Mice.
    J Invest Dermatol. 2025 Aug 8:S0022-202X(25)02323.
    PubMed     Abstract available


  265. BUNICK CG
    Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of Action.
    J Invest Dermatol. 2025 Aug 5:S0022-202X(25)02203.
    PubMed     Abstract available


  266. KITTLER H
    Artificial Intelligence and Skin Disease Scoring: An Opportunity to Reset the Standards.
    J Invest Dermatol. 2025 Aug 4:S0022-202X(25)02269.
    PubMed    


  267. PUIG L
    Repurposing Roflumilast and the Emerging Landscape of Phosphodiesterase 4 Inhibition in Psoriasis.
    J Invest Dermatol. 2025 Aug 4:S0022-202X(25)01857.
    PubMed    


  268. REZNIK AS, Vats K, Singh K, Mizes A, et al
    Emerging Roles of Ferroptosis in Skin Pathophysiology.
    J Invest Dermatol. 2025 Aug 4:S0022-202X(25)01850.
    PubMed     Abstract available


  269. SHOBNAM N, Ratley G, Saksena S, Yadav M, et al
    Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD.
    J Invest Dermatol. 2025;145:1953-1968.
    PubMed     Abstract available


  270. BALUKOFF NC, Houk G, Gonzalez T, Berton Y, et al
    Out of this World: Wound Healing on Earth and in Space.
    J Invest Dermatol. 2025;145:1879-1895.
    PubMed     Abstract available


  271. TOUNI AA, Muttar S, Siddiqui Z, Shivde RS, et al
    Bacillus Subtilis-Derived Exopolysaccharide Halts Depigmentation and Autoimmunity in Vitiligo.
    J Invest Dermatol. 2025;145:2049-2059.
    PubMed     Abstract available


  272. MOLTRASIO C, Moura R, Conti A, Fania L, et al
    Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis Suppurativa.
    J Invest Dermatol. 2025;145:1987-1994.
    PubMed     Abstract available


    July 2025
  273. RANDON PM, Ward NL
    Spatial Proteomics Redefines Psoriasis as a Vertically Stratified, Immunometabolic Tissue State.
    J Invest Dermatol. 2025 Jul 31:S0022-202X(25)02249.
    PubMed    


  274. CHHABRA G, Su S, Shirley CA, Thornton J, et al
    A melanoma-specific gene network analysis identifies MZB1 (marginal zone B and B1 cell-specific protein) as a potential tumor promoter.
    J Invest Dermatol. 2025 Jul 30:S0022-202X(25)02310.
    PubMed     Abstract available


  275. VAN DEN HURK K, Lommen K, Coussement L, van den Kerkhof D, et al
    Comprehensive analysis of the melanoma DNA methylome identifies Lymphocyte Antigen 75 (LY75) methylation as an independent marker predicting poor clinical outcome.
    J Invest Dermatol. 2025 Jul 30:S0022-202X(25)02311.
    PubMed     Abstract available


  276. THOMOVA T, Jedlickova H, Bohm J, Holochova P, et al
    EFFECT OF SYSTEMIC THERAPIES ON SKIN BACTERIOME IN PATIENTS WITH ATOPIC DERMATITIS: A PILOT PROSPECTIVE STUDY.
    J Invest Dermatol. 2025 Jul 28:S0022-202X(25)02307.
    PubMed     Abstract available


  277. CHEN Y, El Mahi Y, Aubin F, Saas P, et al
    Tracking molecular predictors of relapse in psoriasis upon cessation of biologics: identification of highly relevant markers.
    J Invest Dermatol. 2025 Jul 28:S0022-202X(25)02308.
    PubMed    


  278. HUTH S, Marquardt Y, Huth L, Singh K, et al
    An Improved Human 3D Skin Model for Aging Research.
    J Invest Dermatol. 2025 Jul 23:S0022-202X(25)02276.
    PubMed    


  279. OHARAZAWA A, Maimaituxun G, Watanabe K, Nishiyasu T, et al
    Metabolomics of the Skin Dialysate Collected from the Forearm Subjected to Local Heating.
    J Invest Dermatol. 2025 Jul 21:S0022-202X(25)02268.
    PubMed    


  280. PHILIPP T, Nisa Bengu A, Cliff R, Veronica R, et al
    MILK10k: A hierarchical multimodal imaging learning toolkit for diagnosing pigmented and non-pigmented skin cancer and its simulators.
    J Invest Dermatol. 2025 Jul 21:S0022-202X(25)02270.
    PubMed     Abstract available


  281. PEDRO PEREZ AA, Romero Jofre PI, Vidaurre S, Navarrete-Dechent C, et al
    A Review of Metadata and Deep Learning Strategies for Skin Lesion Classification.
    J Invest Dermatol. 2025 Jul 17:S0022-202X(25)02267.
    PubMed    


  282. KASHAF SS, Higuchi H, Han J, Conlan S, et al
    Skin microbiome shifts associated with elevated squamous cell carcinoma risk.
    J Invest Dermatol. 2025 Jul 17:S0022-202X(25)02264.
    PubMed    


  283. DELIC D, Visvanathan S, Xing D, Roy J, et al
    Differential Effects of RORgamma Inhibition on Selected Pathways in Plaque Psoriasis.
    J Invest Dermatol. 2025 Jul 17:S0022-202X(25)02262.
    PubMed    


  284. NG J, Diehl K, Petrie T, Tobey T, et al
    The Melanoma Toolkit for Early Detection Improves Accuracy but Fails to Improve the Number Needed to Biopsy.
    J Invest Dermatol. 2025 Jul 17:S0022-202X(25)02263.
    PubMed    


  285. RAMCKE T, Johannisson S, Vicari E, Enk A, et al
    Autoreactive Tfh cells drive induction of BP-like skin disease.
    J Invest Dermatol. 2025 Jul 7:S0022-202X(25)02246.
    PubMed     Abstract available


  286. PUHR R, Ryan EG, Couturier DL, van Akkooi ACJ, et al
    Transforming Clinical Trials in Skin Cancer Research: Exploring the Potential of Flexible and Innovative Designs.
    J Invest Dermatol. 2025;145:1569-1579.
    PubMed     Abstract available


  287. BAZZINI C, Bertschi NL, Steck O, Luther F, et al
    Human T Helper 9 Cells Rely on Peroxisome Proliferator-Activated Receptor-gamma-Mediated Cystine Uptake to Prevent Lipid Peroxidation and Bioenergetic Failure.
    J Invest Dermatol. 2025;145:1693-1705.
    PubMed     Abstract available


  288. LV S, Zou X, Wang L, Xu Y, et al
    Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China.
    J Invest Dermatol. 2025;145:1633-1642.
    PubMed     Abstract available


  289. SHI Y, Liu YY, Zhen Y, Si HN, et al
    Low-Density Neutrophil Levels Are Correlated with Sporotrichosis Severity: Insights into Subcutaneous Fungal Infection.
    J Invest Dermatol. 2025;145:1753-1769.
    PubMed     Abstract available


  290. KIM KS, Tao B, Kaur H, Mikhail D, et al
    Reporting quality of noninferiority randomized controlled trials for skin disease: a meta-epidemiological study.
    J Invest Dermatol. 2025 Jul 1:S0022-202X(25)02242.
    PubMed     Abstract available


    June 2025
  291. HEINEMANN N, Harder J
    IkappaBzeta: A Delicate Mediator in Skin Homeostasis.
    J Invest Dermatol. 2025 Jun 28:S0022-202X(25)00556.
    PubMed    


  292. HELDER M, Pandeya N, Seviiri M, Olsen CM, et al
    No evidence that genetically predicted circulating retinol is protective for skin cancer.
    J Invest Dermatol. 2025 Jun 26:S0022-202X(25)02235.
    PubMed    


  293. BUNICK CG, Armstrong AW, Grada A, Soliman AM, et al
    The Epidemiology of Atopic Dermatitis Among Adults and Adolescents with Alopecia Areata in the United States.
    J Invest Dermatol. 2025 Jun 26:S0022-202X(25)02236.
    PubMed     Abstract available


  294. WANG H, Liu Z, Pan H, Liu K, et al
    A 3D-Optimized AI Imaging Model for the Skin Tumor Burden Assessment of Mycosis Fungoides.
    J Invest Dermatol. 2025 Jun 24:S0022-202X(25)02144.
    PubMed     Abstract available


  295. ZHOU W, Ring NG, Caldwell R, Milstone LM, et al
    Genotype-environment-driven dysbiosis in the skin microbiome of ichthyosis.
    J Invest Dermatol. 2025 Jun 24:S0022-202X(25)02149.
    PubMed     Abstract available


  296. GELLER S, Liao V, Moy A, Hollmann TJ, et al
    C-C chemokine receptor 8 immunohistochemistry highlights CCR8 as a diagnostic and therapeutic biomarker in cutaneous T-cell lymphoma.
    J Invest Dermatol. 2025 Jun 24:S0022-202X(25)02146.
    PubMed    


  297. DU H, Yang J, Liu P, Zhao L, et al
    Microneedle-mediated intradermal delivery of methotrexate alleviates imiquimod-induced initial and recurrent psoriasis-like skin inflammation by inhibiting IL-17A(+)Vgamma4(+) gammadeltaT cells.
    J Invest Dermatol. 2025 Jun 24:S0022-202X(25)02147.
    PubMed    


  298. GELLER S
    Cutaneous T-Cell Lymphoma after Dupilumab Treatment in Patients with Atopic Dermatitis: A Response Letter to James et al.
    J Invest Dermatol. 2025 Jun 24:S0022-202X(25)00542.
    PubMed    


  299. GARSHICK MS
    Residual Cardiovascular Risk in Psoriasis: What's in the Name?
    J Invest Dermatol. 2025 Jun 23:S0022-202X(25)00554.
    PubMed    


  300. PIHL C, Bjerring P, Andersen F, Haedersdal M, et al
    A Curated and Updated Database of Pharmacological Skin Cancer Preventative Modalities.
    J Invest Dermatol. 2025 Jun 18:S0022-202X(25)01856.
    PubMed    


  301. DANG TVT, Mehdi AM, Kumari S, Khosrotehrani K, et al
    The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases.
    J Invest Dermatol. 2025 Jun 16:S0022-202X(25)00490.
    PubMed     Abstract available


  302. STURGES CI, Jain S, Velasquez M, Gedamu H, et al
    Cutaneous Hormone Sampling and Analysis for Dermatologic Research.
    J Invest Dermatol. 2025 Jun 14:S0022-202X(25)00530.
    PubMed     Abstract available


  303. SCHNEIDER MR, Meier M
    Bringing High-Resolution Spatial Order to Sebaceous Glands.
    J Invest Dermatol. 2025 Jun 11:S0022-202X(25)00526.
    PubMed    


  304. GROLLEAU C, Poisot T, Roux C, Perray L, et al
    Single-cell profiling of lichen planus reveals type I interferon response triggering the interface dermatitis reaction.
    J Invest Dermatol. 2025 Jun 9:S0022-202X(25)00555.
    PubMed     Abstract available


  305. BECKER SL, Vague M, Ortega-Loayza AG
    Insights into the Pathogenesis of Pyoderma Gangrenosum.
    J Invest Dermatol. 2025;145:1305-1322.
    PubMed     Abstract available


  306. WANG J, Ho M, Bunick CG
    Chemical, Biochemical, and Structural Similarities and Differences of Dermatological cAMP Phosphodiesterase-IV Inhibitors.
    J Invest Dermatol. 2025;145:1471-1488.
    PubMed     Abstract available


  307. LI J, Li S, Zhang Q, Liang M, et al
    Apocrine Gland Damage and the Release of Specific Keratins in Early Stage Indicate the Crucial Involvement of Apocrine Glands in Hidradenitis Suppurativa.
    J Invest Dermatol. 2025;145:1371-1384.
    PubMed     Abstract available


  308. FLORA A, Pham J, Woods JA, Radzeika M, et al
    The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial.
    J Invest Dermatol. 2025;145:1396-1406.
    PubMed     Abstract available


  309. CHEN KL, Chiu YE, Vleugels RA, Co DO, et al
    Recent Advances in Juvenile Dermatomyositis: Moving toward Integration of Myositis-Specific Antibody Clinical Phenotypes, IFN-Driven Pathogenesis, and Targeted Therapies.
    J Invest Dermatol. 2025;145:1294-1304.
    PubMed     Abstract available


  310. EL-HOWATI A, Edmans JG, Santocildes-Romero ME, Madsen LS, et al
    A Tissue-Engineered Model of T-Cell-Mediated Oral Mucosal Inflammatory Disease.
    J Invest Dermatol. 2025;145:1447-1458.
    PubMed     Abstract available


    May 2025
  311. MANN C, Ojak G, Hyde I, Beczinski J, et al
    Epidermal IL-36 and CCL17 protein expression distinguish palmar eczema from palmar psoriasis.
    J Invest Dermatol. 2025 May 30:S0022-202X(25)00535.
    PubMed    


  312. JAMES ML, Pink AE, Woolf RT, Batty P, et al
    Response to Lavin et al's paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System.
    J Invest Dermatol. 2025 May 30:S0022-202X(25)00543.
    PubMed    


  313. KENTLEY J, Kurtansky N, Jain M, Cordova M, et al
    Non-invasive diagnosis of melanoma using machine learning and reflectance confocal microscopy.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00539.
    PubMed    


  314. HIERMAIER M, Egu DT, Sigmund AM, Ernst N, et al
    The Multi-kinase Inhibitor Midostaurin Mitigates Loss of Intercellular Adhesion and Skin Blistering in Pemphigus Vulgaris.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00538.
    PubMed     Abstract available


  315. DUZ T, Torocsik D, Simmering A, Wolf P, et al
    High-Resolution Spatial Map of the Human Facial Sebaceous Gland Reveals Marker Genes and Decodes Sebocyte Differentiation.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00540.
    PubMed     Abstract available


  316. OCHIAI S, Larson AR, Mayer JU, Yang J, et al
    Allergic Skin Inflammation Drives IL-4-Dependent Differentiation of Dermal CD11b-low Dendritic Cells.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00536.
    PubMed     Abstract available


  317. KIM JY, Lee EJ, Jang G, Park S, et al
    Targeting IL-24 signaling to restore skin barrier function: Discovery of penta-O-galloyl-beta-D-glucose via in silico screening.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00537.
    PubMed    


  318. FUNCH AB, Weber JF, Mraz V, Kongsbak-Wismann M, et al
    CD8(+) Skin-Resident Memory T Cells Require TCR Signaling for their Persistence in a Mouse Model of Allergic Contact Dermatitis.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00529.
    PubMed     Abstract available


  319. KIM G, Siprashvili Z, Yang X, Meyers JM, et al
    In vivo CRISPRi screen reveals lncRNA portfolio crucial for cutaneous squamous cell carcinoma tumor growth.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00532.
    PubMed     Abstract available


  320. BURKE OM, Ma F, Huang J, Kirsner RS, et al
    Melanoma Incidence and Survival: A SEER Database Study.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00527.
    PubMed    


  321. AKBARIALIABAD H, Bunick CG
    Revisiting RORgammat Inhibition in Plaque Psoriasis: Lessons Learned from BI 730357.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00406.
    PubMed    


  322. HAARMANN-STEMMANN T, Esser C
    Cutaneous Exposure to Per- and Polyfluoroalkyl Substances: Cause for Concern?
    J Invest Dermatol. 2025 May 26:S0022-202X(25)00397.
    PubMed    


  323. BYRD AS, Moreau JM, Petukhova L, Frew J, et al
    Differentiating the Role of Inflammation in Hidradenitis Suppurativa from that in Other Inflammatory Skin Diseases.
    J Invest Dermatol. 2025 May 24:S0022-202X(25)00450.
    PubMed     Abstract available


  324. CAMERA E, Di Nardo A
    A Microbial Shield: Interactions between UVR, cis-Urocanic Acid, and the Skin Microbiome.
    J Invest Dermatol. 2025 May 22:S0022-202X(25)00452.
    PubMed    


  325. YURCHENKO AA, Sharkhith H, Rajabi F, Bogiatzi S, et al
    Integrative Molecular Analysis of Skin Tumors from CYLD Cutaneous Syndrome Patients.
    J Invest Dermatol. 2025 May 22:S0022-202X(25)00496.
    PubMed     Abstract available


  326. MOLLER LBP, Kromann B, Kabatnik S, Hjortlund JH, et al
    Spatial Proteomic Profiling Reveals Increased Levels of Cholesterol Synthesis Proteins in Psoriasis Vulgaris.
    J Invest Dermatol. 2025 May 22:S0022-202X(25)00489.
    PubMed     Abstract available


  327. PERES J, Damerell V, Chauhan J, Popovic A, et al
    Corrigendum to 'TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF' Journal of Investigative Dermatology, Volume 141, Issue 9, September 2021, Pages 2250-2260.
    J Invest Dermatol. 2025 May 21:S0022-202X(24)03018.
    PubMed    


  328. GELFAND JM
    The Visceral Relationship of Psoriasis and Obesity.
    J Invest Dermatol. 2025 May 21:S0022-202X(25)00456.
    PubMed    


  329. GEHLHAUSEN JR, Kong Y, Baker E, Ramachandran S, et al
    Cutaneous lupus features specialized stromal niches and altered retroelement expression.
    J Invest Dermatol. 2025 May 21:S0022-202X(25)00488.
    PubMed     Abstract available


  330. PARAJULI N, Wang Q, Wang J, Yin C, et al
    MicroRNA-17-92 regulate skin Langerhans cell embryonic development through targeting cell proliferation pathways.
    J Invest Dermatol. 2025 May 21:S0022-202X(25)00493.
    PubMed    


  331. BAEZ E, Gyldenlove M, Ben Abdallah H, Emmanuel T, et al
    Oral roflumilast suppresses pro-inflammatory cytokine signaling and reduces CD4+ T cell and neutrophil infiltration in psoriasis.
    J Invest Dermatol. 2025 May 20:S0022-202X(25)00491.
    PubMed     Abstract available


  332. ZHANG J, Yu Y, Zhao P, Yuan L, et al
    Clinical characteristics of hand eczema and its association with atopic dermatitis in the Chinese population: A multicenter cross-sectional study.
    J Invest Dermatol. 2025 May 19:S0022-202X(25)00486.
    PubMed     Abstract available


  333. POLO-SILVEIRA L, Dusza SW, Kentley J, Marchetti MA, et al
    Cutaneous Melanoma Risk Assessment Among Individuals with a High-Risk Nevus Phenotype.
    J Invest Dermatol. 2025 May 13:S0022-202X(25)00478.
    PubMed    


  334. FOWLER EA, Sacramento LA, Bowman BA, Lee B, et al
    Hypoxia and IL-15 cooperate to induce perforin expression by CD8 T cells and promote damage to the skin in murine cutaneous leishmaniasis.
    J Invest Dermatol. 2025 May 13:S0022-202X(25)00479.
    PubMed     Abstract available


  335. RICCI LARA MA, Frutos EL, Rodriguez Kowalczuk MV, Ferraresso MG, et al
    External Validation of an AI Ensemble for Skin Cancer Detection: Enhancing Diagnostic Performance on Dermoscopic Images.
    J Invest Dermatol. 2025 May 9:S0022-202X(25)00469.
    PubMed    


  336. KOTKOWSKA ZK, Haunerdinger V, Waeckerle-Men Y, Kolm-Djamei I, et al
    Inflammatory cutaneous reactions with systemic CD8(+) T-cell responses upon photochemical internalization of antigens in mice.
    J Invest Dermatol. 2025 May 8:S0022-202X(25)00467.
    PubMed     Abstract available


  337. RECKA N, Simons A, Cornell RA, Van Otterloo E, et al
    Epidermal loss of PRMT5 leads to the emergence of an atypical basal keratinocyte-like cell population and defective skin stratification.
    J Invest Dermatol. 2025 May 6:S0022-202X(25)00449.
    PubMed     Abstract available


  338. WANG J, Sun S, Guay H, Chang D, et al
    Classification of skin transcriptome reveals two molecular subtypes in hidradenitis suppurativa.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00463.
    PubMed    


  339. LEE M, Mikol V, Truong V, Attieh E, et al
    Atuzabrutinib Topical Gel Does Not Improve Disease Activity in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from a Phase 2a Trial.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00462.
    PubMed    


  340. FAHMY LM, Adeuyan OO, de Jong A
    CD1a and Lipids as Mediators of T Cell Activation in the Skin.
    J Invest Dermatol. 2025 May 3:S0022-202X(25)00383.
    PubMed     Abstract available


  341. MALACTOU C, Hayes M, Zhang T, Ward S, et al
    Eosinophils and bioactive lipid mediators regulate skin inflammation and cancer growth.
    J Invest Dermatol. 2025 May 2:S0022-202X(25)00461.
    PubMed     Abstract available


  342. JIA BB, Sun BK, Lee EY, Ren B, et al
    Emerging Techniques in Spatial Multiomics: Fundamental Principles and Applications to Dermatology.
    J Invest Dermatol. 2025;145:1017-1032.
    PubMed     Abstract available


  343. KUCERA K, Zenzola N, Hudspeth A, Dubnicka M, et al
    Evaluation of Benzene Presence and Formation in Benzoyl Peroxide Drug Products.
    J Invest Dermatol. 2025;145:1147-1154.
    PubMed     Abstract available


  344. YOSHIMOTO N, Muramastsu K, Ito T, Zheng M, et al
    Type XVII Collagen-Specific CD4(+) T Cells Induce Bullous Pemphigoid by Producing IL-5.
    J Invest Dermatol. 2025;145:1092-1104.
    PubMed     Abstract available


  345. DOELEMAN T, Brussee S, Hondelink LM, Westerbeek DWF, et al
    Deep Learning-Based Classification of Early-Stage Mycosis Fungoides and Benign Inflammatory Dermatoses on H&E-Stained Whole-Slide Images: A Retrospective, Proof-of-Concept Study.
    J Invest Dermatol. 2025;145:1127-1134.
    PubMed     Abstract available


  346. SANABRIA-DE LA TORRE R, Montero-Vilchez T, Garcia-Gavin J, Arias-Santiago S, et al
    Current Insights on Lipidomics in Dermatology: A Systematic Review.
    J Invest Dermatol. 2025;145:1105-1116.
    PubMed     Abstract available


    April 2025
  347. ESTRACH S, Vivier CM, Tosello L, Tissot FS, et al
    Epithelial Fibronectin meshwork controls skin regeneration.
    J Invest Dermatol. 2025 Apr 30:S0022-202X(25)00458.
    PubMed     Abstract available


  348. VIIKLEPP K, Knuutila JS, Nissinen L, Siljamaki E, et al
    Expression of C1q by macrophages and fibroblasts in tumor microenvironment is associated with progression and metastasis of cutaneous squamous cell carcinoma.
    J Invest Dermatol. 2025 Apr 29:S0022-202X(25)00446.
    PubMed     Abstract available


  349. MA C, Cheng M, Xiao T, Qi R, et al
    Mir-574-3p and Mir-125a-5p in Adipose Derived Mesenchymal Stem Cell Exosomes Synergistically Target TGF-beta1/Smad2 Signaling Pathway for the Treatment of Androgenic Alopecia.
    J Invest Dermatol. 2025 Apr 28:S0022-202X(25)00448.
    PubMed     Abstract available


  350. RAMESSUR R, Saklatvala J, Loset M, Thomas LF, et al
    Investigating the Genetic Basis of the Influence of Adiposity on Psoriasis: A Cross-Sectional Study in a Large United Kingdom Population-Based Biobank.
    J Invest Dermatol. 2025 Apr 25:S0022-202X(25)00391.
    PubMed    


  351. EYLENBOSCH A, Lambert JLW
    One Step Closer to Personalized Dosing of Biologics in Psoriasis.
    J Invest Dermatol. 2025 Apr 23:S0022-202X(25)00375.
    PubMed    


  352. CHEN S, Yarygina O, Gutierrez E, Silvers DN, et al
    Transcriptional signature for dysplastic epidermal development in human pre-malignant skin.
    J Invest Dermatol. 2025 Apr 23:S0022-202X(25)00418.
    PubMed    


  353. LECUMBERRI A, Berna-Rico E, Gelfand JM, Svedbom A, et al
    Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts.
    J Invest Dermatol. 2025 Apr 23:S0022-202X(25)00377.
    PubMed     Abstract available


  354. RIACHI M, Bryant D, Ellis J, Hughes C, et al
    Cholesterol pathway gene variants and reduced keratinocyte cholesterol support a final common druggable pathway in hyperproliferative inflammatory skin diseases.
    J Invest Dermatol. 2025 Apr 22:S0022-202X(25)00414.
    PubMed     Abstract available


  355. MERHI R, Boniface K, Seneschal J
    Unveiling the Unseen: Exploring Cellular Dynamics in Nonlesional Vitiligo Skin.
    J Invest Dermatol. 2025 Apr 22:S0022-202X(25)00128.
    PubMed     Abstract available


  356. OKUNO R, Hasegawa S, Hasebe Y, Kawagishi-Hotta M, et al
    Site-specific expression of HOXA genes in skin and its effect on skin elasticity.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00417.
    PubMed     Abstract available


  357. ZHU Y, Zhang C
    Between Light and Shadow: The Enigma of Nonlesional Skin in Vitiligo.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00127.
    PubMed    


  358. PATRA V, Trajanoski S, Joshi A, Lenief V, et al
    Urocanase-positive skin resident bacteria metabolize cis-urocanic acid and in turn reduce the immunosuppressive properties of UV radiation.
    J Invest Dermatol. 2025 Apr 21:S0022-202X(25)00405.
    PubMed     Abstract available


  359. MIECZKOWSKI K, Bakiri L, Griss J, Wagner EF, et al
    A sex-specific anti-inflammatory role for p62 in psoriasis-like disease.
    J Invest Dermatol. 2025 Apr 19:S0022-202X(25)00413.
    PubMed     Abstract available


  360. WANG J, Zhang Y, Xie F, Liu J, et al
    Enhancing Diagnosis of Psoriasis and Inflammatory Skin Diseases: A Spatially Aligned Multimodal Model Integrating Clinical and Dermoscopic Images.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00402.
    PubMed     Abstract available


  361. DEBERG HA, Fahning ML, Varkhande SR, Schlenker JD, et al
    T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00401.
    PubMed     Abstract available


  362. DONG L, Wu N, Cai Z, Yan S, et al
    Tolerogenic monocyte-derived langerhans cells promote melanoma progression and immunotherapy resistance through AhR-COX2 activation.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00404.
    PubMed     Abstract available


  363. YAMAMURA S, Horiguchi H, Kadomatsu T, Miyata K, et al
    Aging-associated mitochondrial decline accelerates skin aging and obesity.
    J Invest Dermatol. 2025 Apr 8:S0022-202X(25)00395.
    PubMed     Abstract available


  364. WARREN WG, Osborn M, Yates A, O'Sullivan SE, et al
    ART26.12, A FATTY ACID-BINDING PROTEIN 5 INHIBITOR, SHOWS EFFICACY IN PRECLINICAL PSORIASIS MODELS.
    J Invest Dermatol. 2025 Apr 8:S0022-202X(25)00393.
    PubMed     Abstract available


  365. DOLIVO DM, Rodrigues AE, Mustoe TA, Galiano RD, et al
    Ethacrynic acid mitigates skin fibrosis through downregulation of S100 family damage-associated molecular pattern expression in the epidermis.
    J Invest Dermatol. 2025 Apr 8:S0022-202X(25)00396.
    PubMed    


  366. SU L, Wang D, Purwin TJ, Ran S, et al
    Selective USP7 inhibition synergizes with MEK1/2 inhibitor to enhance immune responses and potentiate anti-PD-1 therapy in NRAS mutant melanoma.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00384.
    PubMed     Abstract available


  367. STAMATAS GN, Insel R, Sorensen N, Palleja A, et al
    Shifts in Infant Skin Microbiome at 2 Months following Short-term Emollient Use from Birth are Associated with Reduced Prevalence of Atopic Dermatitis at 12 Months in a High-Risk Cohort.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00380.
    PubMed    


  368. FREEMAN E, Anwar S, Ahmad N, Fuller LC, et al
    Skin Health at Risk? Examining the Implications of a United States Exit from the World Health Organization.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00308.
    PubMed    


  369. CHEN M, Chen M, Liu L, Yan P, et al
    Transcriptome and chromatin landscape changes associated with pathogenesis of psoriasis in memory Th and memory Treg cells.
    J Invest Dermatol. 2025 Apr 3:S0022-202X(25)00382.
    PubMed    


  370. XIE J, Ma C, Zhao S, Wu D, et al
    Deubiquitination by USP7 Stabilizes JunD and Activates AIFM2 (FSP1) to Inhibit Ferroptosis in Melanoma.
    J Invest Dermatol. 2025 Apr 3:S0022-202X(25)00381.
    PubMed     Abstract available


  371. PIGORS M, Goletz S, Wang Y, Emtenani S, et al
    Anti-Laminin beta4 IgG Drives Tissue Damage in Anti-p200 Pemphigoid and Shows Interactions with Laminin alpha3 and gamma1/2 Chains.
    J Invest Dermatol. 2025;145:821-830.
    PubMed     Abstract available


  372. MAMMANO F, Paller AS, White TW
    Connexin Hemichannel Inhibition and Human Genodermatoses.
    J Invest Dermatol. 2025;145:790-799.
    PubMed     Abstract available


  373. ZHENG Y, Gong W, Wu Z, Zhang S, et al
    FGF21 Ameliorates Fibroblasts Activation and Systemic Sclerosis by Inhibiting CK2alpha/GLI2 Signaling Axis.
    J Invest Dermatol. 2025;145:842-853.
    PubMed     Abstract available


  374. KANG TJ, Lee SY, Yoon S, Kim EG, et al
    PCSK9 Inhibitors and the Risk of Vitiligo: A Mendelian Randomization Study.
    J Invest Dermatol. 2025;145:812-820.
    PubMed     Abstract available


  375. VASUDEVAN SS, Patel T, DiGiovanni J, Nathan CO, et al
    Current Efficacy, Safety and Survival Outcomes of Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
    J Invest Dermatol. 2025 Apr 1:S0022-202X(25)00379.
    PubMed    


    March 2025
  376. LWIN SM, Griffiths CEM
    The Burma Skincare Initiative Spirit of Partnership Garden: Storytelling through Horticulture.
    J Invest Dermatol. 2025 Mar 28:S0022-202X(25)00291.
    PubMed    


  377. HUI-BECKMAN JW, Kim BE, Lyubchenko T, Hall CF, et al
    Repeated Temperature Fluctuation Exposure Causes Prolonged Skin Barrier Dysfunction.
    J Invest Dermatol. 2025 Mar 28:S0022-202X(25)00373.
    PubMed    


  378. YANG VB, Sams CM, Francis SN, Daneshjou R, et al
    Uncovering Disparities in Skin Tone Representation Among AI Vision-Language Models (VLMs).
    J Invest Dermatol. 2025 Mar 28:S0022-202X(25)00374.
    PubMed    


  379. WANG Y, Wang X, Ming X, Gu Y, et al
    Development of an Artificial Intelligence-Based Model to Precisely Measure Body Surface Area in Psoriasis.
    J Invest Dermatol. 2025 Mar 28:S0022-202X(25)00376.
    PubMed    


  380. HAUGH AM, Fisher DE, Lawrence DP
    Tumor-Infiltrating Lymphocyte Therapy for Melanoma Has Arrived (at Last).
    J Invest Dermatol. 2025 Mar 27:S0022-202X(24)03033.
    PubMed    


  381. GU J, Weller R
    Suberythemal Sun and the Skin.
    J Invest Dermatol. 2025 Mar 27:S0022-202X(25)00307.
    PubMed    


  382. AL-JANABI A, Martin P, Simpson C, Rhys H, et al
    Blood single cell transcriptomic and proteomic signatures of paradoxical eczema in psoriasis patients treated with biologics.
    J Invest Dermatol. 2025 Mar 27:S0022-202X(25)00370.
    PubMed     Abstract available


  383. ZHENG L, Soyer HP, Janda M, Jayasinghe D, et al
    An overview of data analysis approaches and biases in unveiling the impact of COVID 19 on melanoma diagnosis.
    J Invest Dermatol. 2025 Mar 25:S0022-202X(25)00371.
    PubMed    


  384. QUAN T, Qin Z, He T, Fisher GJ, et al
    Integrin alpha11beta1 as a Key Collagen Receptor in Human Skin Dermis: Insight into Fibroblast Function and Skin Dermal Aging.
    J Invest Dermatol. 2025 Mar 24:S0022-202X(25)00364.
    PubMed     Abstract available


  385. ZHANG H, Tang S, Chen X, Wang M, et al
    Association Between Emotional Distress and Atopic Dermatitis: A Cross-Sectional Study.
    J Invest Dermatol. 2025 Mar 24:S0022-202X(25)00365.
    PubMed    


  386. MARGUIER A, Mathiot J, NDao B, Wespiser M, et al
    TIE-2 expressing monocytic myeloid-derived suppressor cells are involved in resistance to anti-PD-1 therapy mediated by angiopoietin 2 in melanoma patients.
    J Invest Dermatol. 2025 Mar 18:S0022-202X(25)00327.
    PubMed    


  387. KIDACKI M, Cho C, Lopez-Giraldez F, Breidbart R, et al
    Spatial transcriptomics reveals differential inflammatory pathways in discoid lupus erythematosus and lichen planus.
    J Invest Dermatol. 2025 Mar 18:S0022-202X(25)00324.
    PubMed    


  388. MOCHIZUKI H, Brooks SG, Mahmoud R, Andrade LF, et al
    The effect of IL17 antibody in psoriasis on brain structural morphology reveals significant changes in the precuneus.
    J Invest Dermatol. 2025 Mar 13:S0022-202X(25)00322.
    PubMed    


  389. MA K, Shafique N, Tortorello G, Dheer A, et al
    Significance of Prognostic Factors Across Tumor Thicknesses in Melanoma: A National Cohort Study.
    J Invest Dermatol. 2025 Mar 12:S0022-202X(25)00321.
    PubMed    


  390. SCOTT RW
    The Beauty of Fibroblasts Is Several Skin Layers Deep and Much Deeper.
    J Invest Dermatol. 2025 Mar 10:S0022-202X(25)00126.
    PubMed    


  391. LEBTIG M, Peschel A, Kretschmer D
    Role of Formyl Peptide Receptor 2 and Toll-Like Receptor 2 in Skin Barrier Function and Atopic Dermatitis.
    J Invest Dermatol. 2025 Mar 9:S0022-202X(25)00100.
    PubMed     Abstract available


  392. WANG Y, Yin H, Li Z, Wu H, et al
    Blood transcriptome signature as indicator and predictor for efficacy of abrocitinib in treatment of atopic dermatitis.
    J Invest Dermatol. 2025 Mar 7:S0022-202X(25)00311.
    PubMed     Abstract available


  393. LANE M, Aubert A, Prudova A, Liu F, et al
    Extracellular Granzyme B mediates degradation of Collagen XVII in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    J Invest Dermatol. 2025 Mar 6:S0022-202X(25)00306.
    PubMed    


  394. YUE L, Pang B, Li G, Zhang C, et al
    Endothelial Piezo1 mediates barrier dysfunction and NLRP3 inflammasomes activation in psoriasis.
    J Invest Dermatol. 2025 Mar 5:S0022-202X(25)00303.
    PubMed     Abstract available


  395. LEE JY, Kim HE, Lee ST, Park J, et al
    The repurposing of Nitazoxanide for psoriasis treatment exerts therapeutic effects through skin metabolic reprogramming.
    J Invest Dermatol. 2025 Mar 3:S0022-202X(25)00298.
    PubMed     Abstract available


  396. CHANG J, Shin K, Lewis JM, Suh HW, et al
    Enhanced Intratumoral Delivery of Immunomodulator Monophosphoryl Lipid A through Hyperbranched Polyglycerol-Coated Biodegradable Nanoparticles.
    J Invest Dermatol. 2025;145:593-604.
    PubMed     Abstract available


  397. SHISHIDO-TAKAHASHI N, Garcet S, Cueto I, Miura S, et al
    Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa.
    J Invest Dermatol. 2025;145:536-547.
    PubMed     Abstract available


  398. YANG H, Chen Y, Wang L, Gan B, et al
    The Fungal Secretory Peptide Micasin Induces Itch by Activating MRGPRX1/C11/A1 on Peripheral Neurons.
    J Invest Dermatol. 2025;145:618-630.
    PubMed     Abstract available


    February 2025
  399. RAMOS R, Plikus MV
    Skin-Associated Cartilage Is a Distinct Type of Lipid-Filled Tissue.
    J Invest Dermatol. 2025 Feb 28:S0022-202X(25)00092.
    PubMed    


  400. KUPPANDA PM, Janda M, Soyer HP, Caffery LJ, et al
    What Are Patients' Perceptions and Attitudes Regarding the Use of Artificial Intelligence in Skin Cancer Screening and Diagnosis? Narrative Review.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00080.
    PubMed     Abstract available


  401. INGEN-HOUSZ-ORO S, Matei I, Gaillet A, Gueudry J, et al
    Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00078.
    PubMed     Abstract available


  402. INGEN-HOUSZ-ORO S, French LE, Wolkenstein P
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: How to Improve the Evaluation of Therapeutic Strategies.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00079.
    PubMed    


  403. DEL VECCHIO G, Nguyen NPN, Ouyang K, Odhiambo CO, et al
    Functional Dynamics of Dendritic Cells in Response to Cutibacterium acnes Strains Associated with Healthy and Acne-prone Skin.
    J Invest Dermatol. 2025 Feb 26:S0022-202X(25)00292.
    PubMed    


  404. MOON H, Kim M, Sim H, Hong S, et al
    Comprehensive profiling of genetic and non-genetic factors that influence skin traits in Asian women from four countries.
    J Invest Dermatol. 2025 Feb 24:S0022-202X(25)00290.
    PubMed     Abstract available


  405. KAMP E, Ascott A, George SMC
    Eczema Severity Scoring in Skin of Color: A Review of Current Best Practice and Need for Future Improvement.
    J Invest Dermatol. 2025 Feb 24:S0022-202X(25)00099.
    PubMed     Abstract available


  406. ZHOU X, Jin Y, Zhu Y, Luo X, et al
    The Role of Crosstalk between Nets and Keratinocytes in Skin Immunity.
    J Invest Dermatol. 2025 Feb 21:S0022-202X(25)00012.
    PubMed     Abstract available


  407. SCHWARZ CW, Blegvad C, Baudry D, Tosi I, et al
    Genetic Risk Factors in Childhood Psoriasis.
    J Invest Dermatol. 2025 Feb 19:S0022-202X(25)00117.
    PubMed    


  408. KIDACKI M, Cho C, Lopez-Giraldez F, Huang B, et al
    PD-1H (VISTA) expression in cutaneous squamous cell carcinoma is correlated with T cell infiltration and activation.
    J Invest Dermatol. 2025 Feb 19:S0022-202X(25)00116.
    PubMed     Abstract available


  409. THOMAS CM, Baudry D, Arkir Z, Coker B, et al
    Personalising biologic therapy in psoriasis: Development, validation and user-testing of a precision dosing dashboard.
    J Invest Dermatol. 2025 Feb 19:S0022-202X(25)00118.
    PubMed     Abstract available


  410. TAKAISHI M, Ishimoto T, Kataoka S, Yagyu KI, et al
    A Newly Identified Spliceosomal Protein AHED is Essential for Homeostasis of the Epidermis.
    J Invest Dermatol. 2025 Feb 18:S0022-202X(25)00111.
    PubMed     Abstract available


  411. BEN ABDALLAH H, Iversen L, Johansen C
    The differential roles of heat shock protein 90 isoforms in skin inflammation: Anti-inflammatory potential of TRAP1 inhibition.
    J Invest Dermatol. 2025 Feb 18:S0022-202X(25)00110.
    PubMed     Abstract available


  412. DE BOER F, Kezic S, van der Lelie G, Motazedi E, et al
    Effect of Repeated Low Dose UVR Exposure on Skin Inflammation Threshold, Skin Biomarkers and Vitamin D in Healthy Adults.
    J Invest Dermatol. 2025 Feb 14:S0022-202X(25)00106.
    PubMed     Abstract available


  413. AZIMI A, Bi L, Bonfil A, Teh R, et al
    Integrated analysis of proteomic and dermoscopy imaging data improves non-invasive classification of benign nevi and melanoma.
    J Invest Dermatol. 2025 Feb 13:S0022-202X(25)00102.
    PubMed    


  414. MATSUMURA Y, Kume M, Furuta J, Koguchi-Yoshioka H, et al
    Possible role of IL-23 inhibition in reduction of circulating IL-17A(+) CD103(+) memory CD8 T cells in psoriasis.
    J Invest Dermatol. 2025 Feb 11:S0022-202X(25)00101.
    PubMed    


  415. VESELY MD, Lizzul PF, Klekotka P, Joller N, et al
    Immune Checkpoint Agonists for Inflammatory Skin Diseases.
    J Invest Dermatol. 2025 Feb 8:S0022-202X(25)00031.
    PubMed    


  416. WHITESIDE TL
    Transfer of Oncologic Signals from Melanoma Cells to Benign Melanocytes by Circulating Tumor-Derived Extracellular Vesicles.
    J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00025.
    PubMed    


  417. ADAM E, Leitgeb B, Danis J, Hajdu A, et al
    Truncating CYLD pathogenic variants in CYLD cutaneous syndrome distinctly influence CYLD proteostasis and NF-kappaB signaling.
    J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00089.
    PubMed    


  418. KIM YH, Myeong SY, Kim Y, Maeng J, et al
    Secreted Phosphoprotein 1-CD44s Axis Downregulation Promotes Melanocyte Senescence through ROS Generation.
    J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00088.
    PubMed    


  419. MEROLA JF, Zhang AJ, Childs BA, Li M, et al
    INTER-RATER AND INTRA-RATER RELIABILITY OF THE CUTANEOUS LUPUS ACTIVITY-INVESTIGATOR GLOBAL ASSESSMENT-REVISED (CLA-IGA-R) INSTRUMENT.
    J Invest Dermatol. 2025 Feb 7:S0022-202X(25)00093.
    PubMed    


  420. SLOMINSKI AT, Kim TK, Janjetovic Z, Slominski RM, et al
    Melatonin and the Skin: Current Progress and Perspectives for Human Health.
    J Invest Dermatol. 2025 Feb 6:S0022-202X(24)03030.
    PubMed     Abstract available


  421. RICHARD W, Moga A, Genain G, Amalric N, et al
    Electrochemistry to monitor skin barrier: a proof-of-concept study on skin differentiation compared to corneometry, TEWL measurement, and High-Performance Liquid Chromatography.
    J Invest Dermatol. 2025 Feb 6:S0022-202X(25)00091.
    PubMed    


  422. HINZ B
    HIF-1 Un-LOX Mechanical Mechanisms in Psoriasis.
    J Invest Dermatol. 2025 Feb 5:S0022-202X(25)00026.
    PubMed    


  423. GRADA A, Issa N
    Boosting Skin Microcirculation for Androgenetic Alopecia: Does It Work?
    J Invest Dermatol. 2025 Feb 4:S0022-202X(25)00011.
    PubMed    


  424. WONG ZY, Ou KQ, Wong ZN, Faderani R, et al
    Comment on "Does Sex Matter? Temporal Analyses of Melanoma Trends among Men and Women Suggest Etiologic Heterogeneity.".
    J Invest Dermatol. 2025 Feb 4:S0022-202X(25)00005.
    PubMed    


  425. KWATRA SG, Stander S, Yosipovitch G, Kim BS, et al
    Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation.
    J Invest Dermatol. 2025;145:249-256.
    PubMed     Abstract available


  426. CHEN Q, Zheng J, Bian Q
    Cell Fate Regulation During the Development of Infantile Hemangioma.
    J Invest Dermatol. 2025;145:266-279.
    PubMed     Abstract available


  427. ERTEL A, Anderegg U, Franz S, Saalbach A, et al
    Dermal White Adipose Tissue-Derived Il-33 Regulates Il-4/13 Expression in Myeloid Cells during Inflammation.
    J Invest Dermatol. 2025;145:370-382.
    PubMed     Abstract available


  428. LI S, Wu Y, Bu D, Hu L, et al
    SERPINB7 Deficiency Increases Legumain Activity and Impairs the Epidermal Barrier in Nagashima-Type Palmoplantar Keratoderma.
    J Invest Dermatol. 2025;145:359-369.
    PubMed     Abstract available


  429. BACHIRI K, Kantar D, Laurent EMN, Gaboriaud P, et al
    DNA Damage Stress Control Is a Truncated Large T Antigen and Euchromatic Histone Lysine Methyltransferase 2-Dependent Central Feature of Merkel Cell Carcinoma.
    J Invest Dermatol. 2025;145:400-410.
    PubMed     Abstract available


  430. NATSUGA K, Cipolat S, Watt FM
    Corrigendum to 'Increased Bacterial Load and Expression of Antimicrobial Peptides in Skin of Barrier-Deficient Mice with Reduced Cancer Susceptibility' Journal of Investigative Dermatology, Volume 136, Issue 1, January 2016, Pages 99-106.
    J Invest Dermatol. 2025;145:459.
    PubMed    


    January 2025
  431. WU S, Wang D, Gu X, Xiao R, et al
    Identifying Research Hotspots and Trends in Psoriasis Literature: Autotuned Topic Modeling with Agent.
    J Invest Dermatol. 2025 Jan 31:S0022-202X(25)00086.
    PubMed     Abstract available


  432. HU J, Zhao Q, Che D, Peng B, et al
    Epidermal Mechanical Scratching-Induced ROS Exacerbates the Itch-Scratch Cycle via TRPA1 Activation on Mast Cells in Atopic Dermatitis.
    J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00076.
    PubMed     Abstract available


  433. KHOSRAVI-HAFSHEJANI T, Werth VP
    Serum IFNalpha as a Biomarker for Cutaneous Lupus: Insights into Disease Activity, Severity, Therapeutic Monitoring and Clinical Trial Application.
    J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00020.
    PubMed    


  434. DUAN J, Karri SS, Forouzesh K, Mortimer T, et al
    Designing and Evaluating Circadian Experiments on Mouse Skin.
    J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00018.
    PubMed     Abstract available


  435. GU J, Wei B, Duan R, Jin J, et al
    Insight into the Relationship between Congenital Large/Giant Melanocytic Nevi and Satellite Nevi.
    J Invest Dermatol. 2025 Jan 29:S0022-202X(25)00084.
    PubMed    


  436. NASSIR S, Yousif M, Li X, Severson KJ, et al
    Multi-omic Sequencing of Intermediate to High-Risk Cutaneous Squamous Cell Carcinoma Identifies Critical Genes and Expression Patterns Associated with Disease and Poor Outcomes.
    J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00082.
    PubMed     Abstract available


  437. ABUABARA K, Kidd SA, Ye M, Tully J, et al
    The impact of childhood stressful life events on atopic dermatitis disease activity and severity.
    J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00081.
    PubMed     Abstract available


  438. MORIOKA N, Ganier C, Watt FM
    Fetal fibroblast heterogeneity defines dermal architecture during human embryonic skin development.
    J Invest Dermatol. 2025 Jan 27:S0022-202X(25)00077.
    PubMed     Abstract available


  439. NAVSARIA LJ, Li Y, Jambusaria A, Wheless LE, et al
    Internal cancers in solid organ transplant recipients with a post-transplant skin cancer: a cohort study.
    J Invest Dermatol. 2025 Jan 24:S0022-202X(25)00030.
    PubMed    


  440. INGEN-HOUSZ-ORO S, de Prost N, Wolkenstein P
    Need for Trial Design Change in Epidermal Necrolysis (Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis): Example of Cyclosporine.
    J Invest Dermatol. 2025 Jan 22:S0022-202X(24)03047.
    PubMed    


  441. GOODERHAM MJ, Mrowietz U, Kadus W, Drda K, et al
    Phase II Randomized Trial of BI 730357, a Novel Oral RORgammat Inhibitor, for Moderate-to-Severe Plaque Psoriasis.
    J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00034.
    PubMed     Abstract available


  442. GOHARA Y, Kinoshita R, Tomonobu N, Jiang F, et al
    An S100A8/A9 neutralizing antibody potently ameliorates contact hypersensitivity and atopic dermatitis symptoms.
    J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00029.
    PubMed     Abstract available


  443. OLESEN CM, Edslev SM, Aasbjerg GN, Yuksel YT, et al
    Subtype specific alterations in the skin microbiome of patients with cutaneous T-cell lymphoma.
    J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00032.
    PubMed    


  444. WANG F, Yi C, Zhong Y, Zhou L, et al
    Downregulated TFPI2 accelerates skin aging by repressing cell cycle via PI3K/Akt/CDC6 pathway.
    J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00033.
    PubMed     Abstract available


  445. CAVES E, Jussila A, Forni MF, Benvie A, et al
    Atgl-dependent adipocyte lipolysis promotes lipodystrophy and restrains fibrogenic responses during skin fibrosis.
    J Invest Dermatol. 2025 Jan 20:S0022-202X(25)00022.
    PubMed     Abstract available


  446. MULLER C, Tschandl P, Rinner C, Kyrgidis A, et al
    The BRAAFF-Annotated Acral Lesions Dataset (BALD): A curated set of dermatoscopic images of acral melanoma and nevi from various sources.
    J Invest Dermatol. 2025 Jan 17:S0022-202X(25)00021.
    PubMed    


  447. SHEN A, Arbesman M, Lodha R, Rayman P, et al
    Germline Pathogenic Variant (gPV) Positive Patients with Melanoma Exhibit Improved Response to Checkpoint Inhibitor Immunotherapy.
    J Invest Dermatol. 2025 Jan 13:S0022-202X(25)00004.
    PubMed    


  448. WEI Y, Wan Z, Jiang Y, Liu Z, et al
    No Causal Association between ACE Inhibitors and Skin Fibrosis Risk: Evidence from Mendelian Randomization.
    J Invest Dermatol. 2025 Jan 13:S0022-202X(25)00013.
    PubMed    


  449. ZHANG M, Li Z, Yang R, Liang L, et al
    Revolutionizing Chronic Wound Treatment: Treating Bleomycin Intralesional Injection-Related Chronic Wounds with 3D Bioprinted Skin Substitutes.
    J Invest Dermatol. 2025 Jan 10:S0022-202X(25)00009.
    PubMed    


  450. MOHR C, Li Y, Navsaria LJ, Hinkston CL, et al
    Allogeneic Hematopoietic Stem-Cell Transplant Recipients and Skin Cancer Risk: A Commercial Claims Cohort Study.
    J Invest Dermatol. 2025 Jan 9:S0022-202X(25)00002.
    PubMed    


  451. MENG Y, Zhou Q, Dian Y, Zeng F, et al
    Ferroptosis: A Targetable Vulnerability for Melanoma Treatment.
    J Invest Dermatol. 2025 Jan 8:S0022-202X(24)03024.
    PubMed     Abstract available


  452. TRIBBLE JT, Brownell I, Cahoon EK, Sargen MR, et al
    A comparative study of Merkel cell carcinoma and melanoma incidence and survival in the United States, 2000-2021.
    J Invest Dermatol. 2025 Jan 6:S0022-202X(25)00001.
    PubMed     Abstract available


  453. PERRAY L, Dorgham K, Mathian A, Grolleau C, et al
    Identification of serum IFN-alpha and BAFF levels as potential biomarkers of activity and severity in cutaneous lupus erythematosus.
    J Invest Dermatol. 2025 Jan 6:S0022-202X(24)03053.
    PubMed    


  454. MEI H, Dai X, Chen W, Luo R, et al
    Intervening CCL8-CCR8 Signaling Reduces Cutaneous Inflammation and Itch in Mice.
    J Invest Dermatol. 2025 Jan 4:S0022-202X(24)03051.
    PubMed    


  455. WANG Z, Hu H, Ou Y, Wang C, et al
    Computer-Aided Assessment of Repigmentation Rates in Vitiligo Patients: Implications for Treatment Efficacy - A Retrospective Study.
    J Invest Dermatol. 2025;145:56-64.
    PubMed     Abstract available


  456. SAMPATH AJ, Westerkam LL, Blum FR, Alhusayen R, et al
    Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens.
    J Invest Dermatol. 2025;145:50-55.
    PubMed     Abstract available


  457. BRYANT D, Barberan-Martin S, Maeshima R, Del Valle Torres I, et al
    RNA Therapy for Oncogenic NRAS-Driven Nevi Induces Apoptosis.
    J Invest Dermatol. 2025;145:122-134.
    PubMed     Abstract available


  458. CAMPBELL AC, Baik JE, Sarker A, Brown S, et al
    Breast Cancer-Related Lymphedema Results in Impaired Epidermal Differentiation and Tight Junction Dysfunction.
    J Invest Dermatol. 2025;145:85-97.
    PubMed     Abstract available


  459. BRIOT J, Pons C, Foucher A, Goudouneche D, et al
    Prolyl Endopeptidase Is Involved in Filaggrinolysis and Cornification.
    J Invest Dermatol. 2025;145:98-108.
    PubMed     Abstract available


  460. WU S, Fang R, Rietveld MH, Torremans JRG, et al
    Identification of Small-Molecule Inhibitors Targeting Different Signaling Pathways in Cancer-Associated Fibroblast Reprogramming under Tumor-Stroma Interaction.
    J Invest Dermatol. 2025;145:65-76.
    PubMed     Abstract available


  461. MOHANTY C, Singh CK, Daccache JA, Damsky W, et al
    Granuloma Annulare Exhibits Mixed Immune and Macrophage Polarization Profiles with Spatial Transcriptomics.
    J Invest Dermatol. 2025;145:109-121.
    PubMed     Abstract available


    December 2024
  462. LEE S, Jung DM, Kang BM, Yoo JG, et al
    Expression of FABP4 in Human Sebaceous Glands and Its Role in Sebum Production: A New Regulator of Sebum Production.
    J Invest Dermatol. 2024 Dec 31:S0022-202X(24)03050.
    PubMed    


  463. DUONG T, Hafer R, Yang HY, Tolotta J, et al
    The Risk of Developing Keratinocyte Malignancies in Patients with Cutaneous T-cell Lymphoma.
    J Invest Dermatol. 2024 Dec 31:S0022-202X(24)03046.
    PubMed    


  464. KURZEN N, Mubarak M, Eigemann J, Seiringer P, et al
    Death associated protein kinase 1 dampens keratinocyte necroptosis and expression of inflammatory genes in lichen planus.
    J Invest Dermatol. 2024 Dec 31:S0022-202X(24)03039.
    PubMed     Abstract available


  465. BLOT L, Bzioueche H, Heim M, Cheli Y, et al
    CLEC12B regulates melanocyte immunity and homeostasis in the skin through the STAT1/IRF1 axis.
    J Invest Dermatol. 2024 Dec 28:S0022-202X(24)03038.
    PubMed     Abstract available


  466. AZEEM M, Helal M, Klein-Hessling S, Serfling E, et al
    NFATc1 fosters allergic contact dermatitis responses by enhancing the induction of IL-17-producing CD8 cells.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03036.
    PubMed     Abstract available


  467. STROTHER C, Bouffard N, Smolynets O, Graham NR, et al
    Localized inflammation in dengue vaccine-induced skin rash is not associated with continuous presence of dengue virus genome.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03037.
    PubMed     Abstract available


  468. TANDON R, Harder I, Stolzl D, Hubenthal M, et al
    Tralokinumab Treatment of Atopic Dermatits Induces A Progressive Transcriptomic Response.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03035.
    PubMed     Abstract available


  469. LEE KJ, Kao YC, Smit DJ, Betz-Stablein B, et al
    Mitochondrial deletion(4977) abundance in melanoma-adjacent skin.
    J Invest Dermatol. 2024 Dec 24:S0022-202X(24)03026.
    PubMed    


  470. SHIME H, Odanaka M, Imai M, Sugiyama D, et al
    Ultraviolet-B irradiation expands skin-resident CD81(+)Foxp3(+) regulatory T cells with a highly activated phenotype.
    J Invest Dermatol. 2024 Dec 24:S0022-202X(24)03025.
    PubMed     Abstract available


  471. THAKKER S, Arbesman J, Klein JC, Sunshine JC, et al
    Three-Dimensional Nuclear Architecture and Genomic Structural Variations in Melanoma.
    J Invest Dermatol. 2024 Dec 24:S0022-202X(24)03032.
    PubMed    


  472. BECCACECE I, Burstein VL, Almeida MA, Gareca JC, et al
    Cutaneous innate lymphoid populations drive IL-17A-mediated immunity in Nannizzia gypsea dermatophytosis.
    J Invest Dermatol. 2024 Dec 23:S0022-202X(24)03029.
    PubMed     Abstract available


  473. TULIC MK, Kovacs D, Bastonini E, Briganti S, et al
    Focusing on the Dark Side of the Moon: Involvement of the Nonlesional Skin in Vitiligo.
    J Invest Dermatol. 2024 Dec 20:S0022-202X(24)02886.
    PubMed     Abstract available


  474. ISKANDAR RJ, Drucker AM
    A Framework to Efficiently Monitor the Comparative Safety of Systemic Immunomodulatory Medications for Atopic Dermatitis.
    J Invest Dermatol. 2024 Dec 20:S0022-202X(24)02961.
    PubMed    


  475. USOLTSEV D, Njauw CN, Ji Z, Kumar R, et al
    Analysis of variants induced by combined ex vivo irradiation and in vivo tumorigenesis suggests a role for the ZNF831 p.R1393Q mutation in cutaneous melanoma development.
    J Invest Dermatol. 2024 Dec 13:S0022-202X(24)03015.
    PubMed     Abstract available


  476. TORRES M, Silberberg G, Vegvari A, Zubarev RA, et al
    The temporal dynamics of proteins in aged skin wound healing and comparison to gene expression.
    J Invest Dermatol. 2024 Dec 13:S0022-202X(24)03014.
    PubMed    


  477. BRAHIMI N, Croitoru D, Saidoune F, Zabihi H, et al
    From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions.
    J Invest Dermatol. 2024 Dec 10:S0022-202X(24)01883.
    PubMed     Abstract available


  478. SALAVESSA L, Delevoye C
    Trash to Treasure: The (Trans)formation of Pigment Organelles in Skin Keratinocytes.
    J Invest Dermatol. 2024 Dec 8:S0022-202X(24)02901.
    PubMed    


  479. HAO J, Xu H, Luo M, Yu W, et al
    Corrigendum to The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy [Journal of Investigative Dermatology, Volume 138, Issue 1, January 2018, Pages 159-170].
    J Invest Dermatol. 2024 Dec 6:S0022-202X(24)02184.
    PubMed    


  480. YASSKY D, Kim BS
    Mouse Models of Itch.
    J Invest Dermatol. 2024;144:2634-2644.
    PubMed     Abstract available


  481. STEINBECK BJ, Gao XD, McElroy AN, Pandey S, et al
    Twin Prime Editing Mediated Exon Skipping/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa.
    J Invest Dermatol. 2024;144:2764-2777.
    PubMed     Abstract available


  482. MURTHY S, Patzelt S, Kunstner A, Busch H, et al
    Intravenous Ig Ameliorates Disease in a Murine Model of Anti-Laminin 332 Mucous Membrane Pemphigoid.
    J Invest Dermatol. 2024;144:2671-2681.
    PubMed     Abstract available


  483. STEINERT L, Fuchs M, Sigmund AM, Didona D, et al
    Desmosomal Hyper-Adhesion Affects Direct Inhibition of Desmoglein Interactions in Pemphigus.
    J Invest Dermatol. 2024;144:2682-2694.
    PubMed     Abstract available


    November 2024
  484. LIU X, Janknecht R, Asadbeigi SN, Perry L, et al
    The influence of melanoma extracellular vesicles on benign melanocytes: a role for PRAME in modulation of the tumor microenvironment.
    J Invest Dermatol. 2024 Nov 26:S0022-202X(24)02959.
    PubMed     Abstract available


  485. BALSINI P, Weinzettl P, Samardzic D, Zila N, et al
    Stiffness-dependent LOX regulation via HIF-1 drives extracellular matrix modifications in psoriasis.
    J Invest Dermatol. 2024 Nov 25:S0022-202X(24)02958.
    PubMed     Abstract available


  486. TONG X, Burks HE, Ren Z, Koetsier JL, et al
    Crosstalk in Skin: Loss of Desmoglein 1 in Keratinocytes Inhibits BRAF(V600E)-induced Cellular Senescence in Human Melanocytes.
    J Invest Dermatol. 2024 Nov 22:S0022-202X(24)02955.
    PubMed     Abstract available


  487. BOIX J, Knuever J, Niehoff N, Sen A, et al
    Constitutive HIF-1alpha expression in the epidermis fuels proliferation and is essential for effective barrier formation.
    J Invest Dermatol. 2024 Nov 21:S0022-202X(24)02951.
    PubMed     Abstract available


  488. YU Z, Tang X, Chen Z, Hu Y, et al
    Role of ADAM10/17-mediated Cleavage of LAG3 in the Impairment of Immunosuppression in Psoriasis.
    J Invest Dermatol. 2024 Nov 19:S0022-202X(24)02948.
    PubMed     Abstract available


  489. YANG J, Liu Z, Hu X, Zhang X, et al
    Skin-resident gammadelta T cells mediate potent and selective antitumor cytotoxicity through directed chemotactic migration and mobilization of cytotoxic granules.
    J Invest Dermatol. 2024 Nov 19:S0022-202X(24)02949.
    PubMed     Abstract available


  490. SEYRAN B, Avila I, Galvan C, Robles G, et al
    Inhibition of pyruvate oxidation diminishes melanoma progression.
    J Invest Dermatol. 2024 Nov 18:S0022-202X(24)02902.
    PubMed    


  491. LEE SS, Martinez Pena EG, Willis AA, Wang CC, et al
    Cell Therapy and the Skin: Great Potential but in Need of Optimization.
    J Invest Dermatol. 2024 Nov 12:S0022-202X(24)02159.
    PubMed     Abstract available


  492. PARK HJ, Lee SW, Kim TC, Park YH, et al
    Topical Application of Nano-sized Graphene Oxide Cream Ameliorates Acute Skin Inflammation in Mice.
    J Invest Dermatol. 2024 Nov 8:S0022-202X(24)02877.
    PubMed     Abstract available


  493. ALDEA D, Macagno N, Marechal E, Moreno M, et al
    Deconvoluted methylation profiles discriminate between closely related melanocytic nevi.
    J Invest Dermatol. 2024 Nov 8:S0022-202X(24)02878.
    PubMed    


  494. GUO L, Bilimoria SN, Kikuchi R, Hao A, et al
    Chronic Obstructive Pulmonary Disease Outcomes in Psoriasis Patients.
    J Invest Dermatol. 2024 Nov 8:S0022-202X(24)02879.
    PubMed    


  495. HORSLEY V, Dadzie OE, Hall R, Jablonski NG, et al
    Disentangling Race from Skin Color in Modern Biology and Medicine.
    J Invest Dermatol. 2024 Nov 6:S0022-202X(24)02108.
    PubMed     Abstract available


  496. YEW YW, Loh M, Brown SJ
    Understanding Atopic Dermatitis in Asian and European Population Cohorts Using Complementary Omics Techniques.
    J Invest Dermatol. 2024 Nov 5:S0022-202X(24)02171.
    PubMed     Abstract available


  497. LOMAKIN IB, Devarkar SC, Grada A, Bunick CG, et al
    Mechanistic Basis for the Translation Inhibition of Cutibacterium acnes by Clindamycin.
    J Invest Dermatol. 2024;144:2553-2561.
    PubMed     Abstract available


  498. ZEYER KA, Bornert O, Nelea V, Bao X, et al
    Dipeptidyl Peptidase-4-Mediated Fibronectin Processing Evokes a Profibrotic Extracellular Matrix.
    J Invest Dermatol. 2024;144:2477-2487.
    PubMed     Abstract available


  499. PATEL J, Deng J, Kambala A, Lee KK, et al
    Spatial Mass Cytometry-Based Single-Cell Imaging Reveals a Disrupted Epithelial-Immune Axis in Prurigo Nodularis.
    J Invest Dermatol. 2024;144:2501-2512.
    PubMed     Abstract available


  500. GUTIERREZ-GARCIA C, Robles-Espinoza CD
    MicroRNA Quantification as an Accurate and Cost-Effective Method to Diagnose Acral Melanoma.
    J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02098.
    PubMed    


  501. MASISON J, Lehmann HP, Wan J
    Utilization of Computable Phenotypes in Electronic Health Record Research: A Review and Case Study in Atopic Dermatitis.
    J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02103.
    PubMed     Abstract available


  502. WEI G, Tran MM, Orsillo L, Mirza FN, et al
    A Geospatial Analysis of the Association between Access to Tanning Bed Facilities and Melanoma in the United States New England Region.
    J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02172.
    PubMed     Abstract available


    October 2024
  503. NAKATSUJI T, Cheng JY, Butcher A, Shafiq F, et al
    Topical ivermectin treatment of rosacea changes the bacterial microbiome of the skin.
    J Invest Dermatol. 2024 Oct 29:S0022-202X(24)02869.
    PubMed    


  504. CHANG CT, Pathmarajah P, Allerup J, Jafry S, et al
    DDI-2: A Diverse Skin Condition Image Dataset Representing Self-Identified Asian Patients.
    J Invest Dermatol. 2024 Oct 29:S0022-202X(24)02868.
    PubMed    


  505. LI Z, Schneikert J, Bal G, Jin M, et al
    Intrinsic regulatory mechanisms protect human skin mast cells from excessive MRGPRX2 activation - paucity in LAD2 cells contributes to hyperresponsiveness of the mast cell line.
    J Invest Dermatol. 2024 Oct 29:S0022-202X(24)02875.
    PubMed    


  506. CUESTA-MARGOLLES G, Schlecht-Louf G, Bachelerie F
    ACKR3 in Skin Homeostasis, an Overlooked Player in the CXCR4/CXCL12 Axis.
    J Invest Dermatol. 2024 Oct 28:S0022-202X(24)02097.
    PubMed     Abstract available


  507. GRICE EA, Brennan-Crispi D, Rodriguez N, Margolis DJ, et al
    Penn Academy for Skin Health (PASH): An Experiential Pipeline Program in Skin Biology and Dermatology for High-School Students.
    J Invest Dermatol. 2024 Oct 26:S0022-202X(24)02174.
    PubMed    


  508. GELFAND JM
    Psoriasis: Disease Modification Today, Cure Tomorrow.
    J Invest Dermatol. 2024 Oct 24:S0022-202X(24)02190.
    PubMed    


  509. LWIN SM, Azrielant S, He J, Griffiths CEM, et al
    Curing Psoriasis.
    J Invest Dermatol. 2024 Oct 22:S0022-202X(24)02161.
    PubMed     Abstract available


  510. HONG SP, Batzorig U, Fernandez-Mendez C, Chen Y, et al
    HNRNPU is essential for proper murine skin development.
    J Invest Dermatol. 2024 Oct 9:S0022-202X(24)02179.
    PubMed    


  511. EDER L, Caucheteux SM, Afiuni-Zadeh S, Croitoru D, et al
    Imaging Mass Cytometry in Psoriatic Disease reveals immune profile heterogeneity in skin and synovial tissue.
    J Invest Dermatol. 2024 Oct 9:S0022-202X(24)02180.
    PubMed     Abstract available


  512. KUENZEL NA, Dobner J, Reichert D, Rossi A, et al
    Vdelta1 T cells integrated in full thickness skin equivalents: a model for the role of human skin-resident gammadeltaT cells.
    J Invest Dermatol. 2024 Oct 7:S0022-202X(24)02173.
    PubMed     Abstract available


  513. DAI X, Mizukami Y, Watanabe K, Tsuda T, et al
    Trehalose prevents IL-4/IL-13-induced skin barrier impairment by suppressing IL-33 expression and increasing Nrf2 activation in human keratinocytes in vitro.
    J Invest Dermatol. 2024 Oct 7:S0022-202X(24)02175.
    PubMed     Abstract available


  514. ZHU X, Dai X, Chen W, Li Y, et al
    Chi3l1 Knockout Mitigates Chronic Itch and Cutaneous Inflammation in Mice.
    J Invest Dermatol. 2024 Oct 2:S0022-202X(24)02164.
    PubMed    


  515. GURI-LAMCE I, Alrokh Y, Graham C, Maeshima R, et al
    Lipid Nanoparticles Efficiently Deliver the Base Editor ABE8e for COL7A1 Correction in Dystrophic Epidermolysis Bullosa Fibroblasts In Vitro.
    J Invest Dermatol. 2024;144:2314-2317.
    PubMed    


  516. WASSON CW, De Lorenzis E, Clavane EM, Ross RL, et al
    The beta-Secretase BACE1 Drives Fibroblast Activation in Systemic Sclerosis through the APP/beta-Catenin/Notch Signaling Axis.
    J Invest Dermatol. 2024;144:2197-2210.
    PubMed     Abstract available


  517. WANG X, Yik-Lok Chung C, Yoshioka A, Hashimoto S, et al
    Chemo-Senolytic Therapeutic Potential against Angiosarcoma.
    J Invest Dermatol. 2024;144:2285-2297.
    PubMed     Abstract available


  518. WANG Y, Zhao S, Zhang X, Xia D, et al
    Single-Cell Transcriptome Analysis Reveals Interaction between CCL19+ Inflammatory Keratinocytes and CCR7+ Dendritic Cells and B Cells in Pemphigus.
    J Invest Dermatol. 2024;144:2301-2305.
    PubMed    


  519. SAYAR SB, Has C
    Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation.
    J Invest Dermatol. 2024;144:2221-2229.
    PubMed     Abstract available


  520. NATTKEMPER LA, Kim BS, Yap QV, Hoon MA, et al
    Increased Systemic Levels of Centrally Acting B-Type Natriuretic Peptide Are Associated with Chronic Itch of Different Types.
    J Invest Dermatol. 2024;144:2267-2272.
    PubMed     Abstract available


  521. INGOLD N, Seviiri M, Ong JS, Gordon S, et al
    Genetic Analysis of Perceived Youthfulness Reveals Differences in How Men's and Women's Age Is Assessed.
    J Invest Dermatol. 2024;144:2230-2239.
    PubMed     Abstract available


  522. SCHNEEWEISS MC, Glynn RJ, Wyss R, Anand P, et al
    A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice.
    J Invest Dermatol. 2024 Oct 1:S0022-202X(24)02169.
    PubMed     Abstract available


    September 2024
  523. MEANT A, Moussa O, Lebeau B, Goncalves C, et al
    Combined inhibition of MNK signaling and BET proteins reveals TGM2 as a novel vulnerability in melanoma.
    J Invest Dermatol. 2024 Sep 30:S0022-202X(24)02160.
    PubMed    


  524. BOGLE R, Patrick MT, Sreeskandarajan S, Gharaee-Kermani M, et al
    Profiling lncRNA in psoriatic skin using scRNA-seq.
    J Invest Dermatol. 2024 Sep 27:S0022-202X(24)02156.
    PubMed     Abstract available


  525. FRISOLI ML, Ko WC, Martinez N, Afshari K, et al
    Single cell RNA-sequencing reveals molecular signatures that distinguish allergic from irritant contact dermatitis.
    J Invest Dermatol. 2024 Sep 26:S0022-202X(24)02152.
    PubMed     Abstract available


  526. DI GIROLAMO D, Di Iorio E, Missero C
    Molecular and Cellular Function of p63 in Skin Development and Genetic Diseases.
    J Invest Dermatol. 2024 Sep 26:S0022-202X(24)02076.
    PubMed     Abstract available


  527. SOLER-SAEZ I, Karz A, Hidalgo MR, Gomez-Cabanes B, et al
    Unveiling common transcriptomic features between melanoma brain metastases and neurodegenerative diseases.
    J Invest Dermatol. 2024 Sep 24:S0022-202X(24)02149.
    PubMed     Abstract available


  528. BEYLOT-BARRY M, Staumont-Salle D
    Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story.
    J Invest Dermatol. 2024 Sep 23:S0022-202X(24)02083.
    PubMed    


  529. MATSUSHIMA Y, Hwang ST, Simon SI
    The Skinny on Dermal Fat and Its Anti-Inflammatory Role in Psoriasis.
    J Invest Dermatol. 2024 Sep 20:S0022-202X(24)02072.
    PubMed    


  530. LIU Y, Andersen B, Gudjonsson JE, Plikus MV, et al
    Ancestral Diversity of Skin Reaches Single-Cell Resolution.
    J Invest Dermatol. 2024 Sep 20:S0022-202X(24)02071.
    PubMed    


  531. CASSAGNE M, Galiacy S, Kychygina A, Chapotot E, et al
    Superficial Conjunctival Cells from Dupilumab-treated Atopic Dermatitis Patients with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature.
    J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02102.
    PubMed     Abstract available


  532. CHEN H, Chen Y, Zhou Y, Cao S, et al
    Optimizing Skin Surface Metabolomics: A Comprehensive Evaluation of Sampling Methods, Extraction Solvents, and Analytical Techniques.
    J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02105.
    PubMed     Abstract available


  533. SAITO Y, Lotti R, Kimura H, Hasegawa A, et al
    Advancements in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: Utilizing Fas-Fas Ligand Inhibition to Target Cell Death Signaling Pathways for Practical Human Application.
    J Invest Dermatol. 2024 Sep 18:S0022-202X(24)02106.
    PubMed    


  534. CHEN XB, Zheng YX, Guo TT, Xu F, et al
    Inhibition of epidermal isoleucyl-tRNA synthetase ameliorates psoriasis-like skin lesions via JAK2/STAT3/CXCL16 signaling pathway.
    J Invest Dermatol. 2024 Sep 16:S0022-202X(24)02095.
    PubMed    


  535. JUNGWIRTH U, Walko G
    Boosting Skin Wound Healing by Agrin-Mediated YAP/TAZ Activation.
    J Invest Dermatol. 2024 Sep 14:S0022-202X(24)02070.
    PubMed    


  536. CEPICA TB, Gupta R, Werth VP, Chong BF, et al
    Severity Scores for Cutaneous Lupus Erythematosus.
    J Invest Dermatol. 2024 Sep 14:S0022-202X(24)02074.
    PubMed     Abstract available


  537. CHHABRA G, Ahmad N
    Mystery of Melanotransferrin in Melanoma.
    J Invest Dermatol. 2024 Sep 14:S0022-202X(24)01994.
    PubMed    


  538. CHAI AC, Siegwart DJ, Wang RC
    Nucleic Acid Therapy for the Skin.
    J Invest Dermatol. 2024 Sep 13:S0022-202X(24)02062.
    PubMed     Abstract available


  539. HAYRINEN M, Teppo HR, Vakeva L, Ranki A, et al
    Tumor RNA sequencing identifies a group of Mycosis Fungoides patients with failure of skin-directed therapies.
    J Invest Dermatol. 2024 Sep 6:S0022-202X(24)02084.
    PubMed    


  540. BROOKS SG, Mahmoud RH, Lin RR, Fluhr JW, et al
    The Skin Acid Mantle: An Update on Skin pH.
    J Invest Dermatol. 2024 Sep 5:S0022-202X(24)01971.
    PubMed     Abstract available


  541. GORESKI H, Ilic D, Flacher V, van den Bogaard E, et al
    NETSKINMODELS: A European Network for Skin Engineering and Modeling.
    J Invest Dermatol. 2024 Sep 3:S0022-202X(24)01897.
    PubMed    


  542. PRIMIERO CA, Janda M, Soyer HP
    Skin 2.0: How Cutaneous Digital Twins Could Reshape Dermatology.
    J Invest Dermatol. 2024 Sep 2:S0022-202X(24)01973.
    PubMed    


  543. PEREZ OD, Tkaczyk ER, Petukhova L
    From the Microscopic Sweat Gland to Large Datasets: The Power of Quantitative Traits in Dermatology.
    J Invest Dermatol. 2024;144:1912-1914.
    PubMed    


  544. POPP C, Miller W, Eide C, Tolar J, et al
    Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa.
    J Invest Dermatol. 2024;144:1943-1953.
    PubMed     Abstract available


  545. SECHI A, Tosti A
    Correlating Cicatricial Alopecia and Cardiovascular Risk: Emerging Insights.
    J Invest Dermatol. 2024;144:1915-1916.
    PubMed    


  546. DEL CANO LR, South AP, O'Toole EA, Kelsell DP, et al
    A Role for Aquaporin-5 Variants in Regulation of the Actin Cytoskeleton in Non-Epidermolytic Palmoplantar Keratoderma.
    J Invest Dermatol. 2024;144:2092-2096.
    PubMed    


  547. LE Y, Zhang J, Lin Y, Ren J, et al
    S100A9 Exacerbates the Inflammation in Rosacea through Toll-Like Receptor 4/MyD88/NF-kappaB Signaling Pathway.
    J Invest Dermatol. 2024;144:1985-1993.
    PubMed     Abstract available


  548. LEISTI P, Huilaja L, Jokelainen J, Varpuluoma O, et al
    Epidemiology and Comorbidities of Mucous Membrane Pemphigoid: A National Cohort Study.
    J Invest Dermatol. 2024;144:2078-2080.
    PubMed    


  549. HWANG AS, Kechter JA, Li X, Hughes A, et al
    Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label Study.
    J Invest Dermatol. 2024;144:1994-2001.
    PubMed     Abstract available


  550. LEE JY, Lim HJ, Kim SH, Lee GJ, et al
    Decreased CD19(+)CD24(hi)CD38(hi) Regulatory B Cells in Alopecia Areata.
    J Invest Dermatol. 2024;144:2080-2083.
    PubMed    


    August 2024
  551. PARK K, Shin KO, Kim YI, Nielsen-Scott AL, et al
    Sphingosine-1-phosphate-cathelicidin axis plays a pivotal role in the development of cutaneous squamous cell carcinoma.
    J Invest Dermatol. 2024 Aug 30:S0022-202X(24)02069.
    PubMed     Abstract available


  552. FAWAY E, Poirier W, Marechal F, Poumay Y, et al
    Expression of fungal and host markers in models of dermatophytosis on mice and human epidermis.
    J Invest Dermatol. 2024 Aug 30:S0022-202X(24)02073.
    PubMed     Abstract available


  553. PARIKH S, Levy C
    The Hungry Side of Skin.
    J Invest Dermatol. 2024 Aug 29:S0022-202X(24)00448.
    PubMed    


  554. LU KQ, Gianneschi NC
    Synthetic Melanin as a Topical Agent for Accelerated Skin Repair.
    J Invest Dermatol. 2024 Aug 28:S0022-202X(24)01981.
    PubMed    


  555. HARMON RM, Ayers JL, McCarthy EF, Kowalczyk AP, et al
    Pumping the Breaks on Acantholytic Skin Disorders: Targeting Calcium Pumps, Desmosomes, and Downstream Signaling in Darier, Hailey-Hailey, and Grover Disease.
    J Invest Dermatol. 2024 Aug 28:S0022-202X(24)01925.
    PubMed     Abstract available


  556. CHEUNG ST, Do Y, Kim E, Rella A, et al
    G Protein-Coupled Receptors in Skin Aging.
    J Invest Dermatol. 2024 Aug 25:S0022-202X(24)01919.
    PubMed     Abstract available


  557. GOLDSTEIN NB, Berk Z, Tomb L, Hu J, et al
    Phosphodiesterase-4 inhibitors increase pigment cells proliferation and melanization in cultured melanocytes and within a 3D skin equivalent model.
    J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02055.
    PubMed     Abstract available


  558. TIRTIAUX B, Ianiri G, De Glas V, Denil E, et al
    Invasion of human epidermis by Malassezia furfur is strain dependent.
    J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02061.
    PubMed    


  559. RUTJES C, Mothershaw A, D'Alessandro BM, Primiero CA, et al
    Combining Automated Lesion Risk And Change Assessment Improves Melanoma Detection: A Retrospective Accuracy Study.
    J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02060.
    PubMed    


  560. DEACON DC, Stubben C, Marcacci E, Stone CJ, et al
    Classification of Cutaneous Melanoma and Melanocytic Nevi with microRNA Ratios is Preserved in the Acral Melanoma Subtype.
    J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02063.
    PubMed    


  561. QIU Y, Jiang W, Feng D, Yu Y, et al
    Resolving 3D genomic landscape of CD4+ T cells in the peripheral blood of patients with psoriasis.
    J Invest Dermatol. 2024 Aug 23:S0022-202X(24)02064.
    PubMed     Abstract available


  562. KUMARAN G, Carroll L, Muirhead N, Bottomley MJ, et al
    How Can Spatial Transcriptomic Profiling Advance Our Understanding of Skin Diseases?
    J Invest Dermatol. 2024 Aug 21:S0022-202X(24)01926.
    PubMed     Abstract available


  563. DE SILVA K, Yan J
    Immune Landscape within Cutaneous Lesions of Human Bullous Pemphigoid.
    J Invest Dermatol. 2024 Aug 21:S0022-202X(24)00364.
    PubMed    


  564. ROOP DR, Krieg T, Werner S, Yuspa S, et al
    Montagna Symposium on the Biology of Skin 70(th) Anniversary: Visualizing the Future!
    J Invest Dermatol. 2024 Aug 20:S0022-202X(24)00305.
    PubMed    


  565. SCHRADER AMR, van Engeland J, Willemze R, Vermaat JSP, et al
    DETECTION OF CIRCULATING TUMOR DNA FOR DISEASE MONITORING IN PATIENTS WITH PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA, LEG TYPE.
    J Invest Dermatol. 2024 Aug 16:S0022-202X(24)01996.
    PubMed    


  566. GOMES MLNP, Krijnen PAJ, Middelkoop E, Niessen HWM, et al
    Fetal Skin Wound Healing: Key Extracellular Matrix Components and Regulators in Scarless Healing.
    J Invest Dermatol. 2024 Aug 16:S0022-202X(24)01863.
    PubMed     Abstract available


  567. DE PESSEMIER B, Lopez CD, Taelman S, Verdonck M, et al
    COMPARATIVE WHOLE METAGENOME ANALYSIS IN LESIONAL AND NON-LESIONAL SCALP AREAS OF PSORIASIS CAPITIS PATIENTS AND HEALTHY INDIVIDUALS.
    J Invest Dermatol. 2024 Aug 9:S0022-202X(24)01984.
    PubMed     Abstract available


  568. QUILEZ C, Bebiano LB, Jones E, Maver U, et al
    Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments.
    J Invest Dermatol. 2024 Aug 9:S0022-202X(24)01499.
    PubMed     Abstract available


  569. CHOI D, Bakhtiari M, Pilcher W, Huang C, et al
    Single-cell Analysis of Debrided Diabetic Foot Ulcers Reveals Dysregulated Wound Healing Environment in non-Hispanic Blacks.
    J Invest Dermatol. 2024 Aug 8:S0022-202X(24)01979.
    PubMed     Abstract available


  570. SIMMONS J, Gallo RL
    The Central Roles of Keratinocytes in Coordinating Skin Immunity.
    J Invest Dermatol. 2024 Aug 7:S0022-202X(24)01882.
    PubMed     Abstract available


  571. ADAWI W, Ro C, Scoville D, Liang Y, et al
    The epithelial transcriptome of hidradenitis suppurativa tunnels is more similar to cutaneous squamous cell carcinoma than to benign infundibular cysts.
    J Invest Dermatol. 2024 Aug 7:S0022-202X(24)01980.
    PubMed    


  572. SUH JH, Lee Y, Jin SP, Kim EJ, et al
    Adiponectin prevents skin inflammation in rosacea by suppressing S6 phosphorylation in keratinocytes.
    J Invest Dermatol. 2024 Aug 7:S0022-202X(24)01982.
    PubMed     Abstract available


  573. JONES MR, Jones J, Pandu P, Liu C, et al
    Neurturin Growth Factor Enhances the Acute Cytokine Response of Inflamed Skin.
    J Invest Dermatol. 2024 Aug 7:S0022-202X(24)01978.
    PubMed     Abstract available


  574. LEE CN, Hong YK, Cheng HC, Chi WY, et al
    Mechanical Stretch Exacerbates Imiquimod-Induced Dermatitis Associated with Increased IL-1beta and IL-6 Production.
    J Invest Dermatol. 2024 Aug 3:S0022-202X(24)01977.
    PubMed    


  575. OGAWA-MOMOHARA M, Vazquez T, Chin F, Sharma M, et al
    Multiplexed mass cytometry of cutaneous lupus erythematosus and dermatomyositis skin: An in-depth, B cell directed immunoprofile.
    J Invest Dermatol. 2024 Aug 2:S0022-202X(24)01969.
    PubMed    


  576. PARK S, Bell A, Gibson R, Masson R, et al
    Advances in Hidradenitis Suppurativa Pathogenesis and Therapies from the Symposium on HS Advances 2023.
    J Invest Dermatol. 2024;144:1681-1684.
    PubMed    


  577. SCHELL SL, Nelson AM
    Setting the Stage for Standardized Reporting of Clinical and Demographic Information in Laboratory-Based Studies of Hidradenitis Suppurativa.
    J Invest Dermatol. 2024;144:1689-1695.
    PubMed     Abstract available


  578. PAYNE AS, Manfredo Vieira S
    Bruton's Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier.
    J Invest Dermatol. 2024;144:1667-1670.
    PubMed    


  579. WELLER RB
    Sunlight: Time for a Rethink?
    J Invest Dermatol. 2024;144:1724-1732.
    PubMed     Abstract available


  580. MACRAE VE
    The Adaptive Immune System: A New Pseudoxanthoma Elasticum Protagonist?
    J Invest Dermatol. 2024;144:1670-1672.
    PubMed    


  581. MURRELL DF, Caux F, Patsatsi A, Hagino O, et al
    Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study.
    J Invest Dermatol. 2024;144:1762-1771.
    PubMed     Abstract available


  582. WU Y, Yang Y, Lin Y, Ding Y, et al
    Emerging Role of Fibroblasts in Vitiligo: A Formerly Underestimated Rising Star.
    J Invest Dermatol. 2024;144:1696-1706.
    PubMed     Abstract available


  583. BRAMPTON C, Pomozi V, Le Corre Y, Zoll J, et al
    Bone Marrow-Derived ABCC6 Is an Essential Regulator of Ectopic Calcification In Pseudoxanthoma Elasticum.
    J Invest Dermatol. 2024;144:1772-1783.
    PubMed     Abstract available


  584. MALIGA Z, Kim DY, Bui AN, Lin JR, et al
    Immune Profiling of Dermatologic Adverse Events from Checkpoint Blockade Using Tissue Cyclic Immunofluorescence: A Pilot Study.
    J Invest Dermatol. 2024;144:1887-1890.
    PubMed    


  585. LI Y, Chen W, Zhu X, Mei H, et al
    Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway.
    J Invest Dermatol. 2024;144:1829-1842.
    PubMed     Abstract available


  586. JAIRATH NK, Qiblawi S, Jeha GM, Pahalyants V, et al
    Leveraging OpenAI's Advanced Data Analysis Tool in Dermatology: Opportunities and Challenges.
    J Invest Dermatol. 2024;144:1879-1882.
    PubMed    


  587. VIKAR S, Szilveszter KP, Koszoru K, Sardy M, et al
    The Syk Inhibitor Entospletinib Abolishes Dermal-Epidermal Separation in a Fully Human Ex Vivo Model of Bullous Pemphigoid.
    J Invest Dermatol. 2024;144:1733-1742.
    PubMed     Abstract available


  588. WANG D, Chen W, Wang Y, Yu J, et al
    Genome-Wide Meta-Analysis Identifies 11 Susceptibility Variants of Vitiligo in the Chinese Han Population.
    J Invest Dermatol. 2024;144:1843-1849.
    PubMed     Abstract available


    July 2024
  589. SON DO, Benitez R, Diao L, Hinz B, et al
    How to Keep Myofibroblasts under Control: Culture of Mouse Skin Fibroblasts on Soft Substrates.
    J Invest Dermatol. 2024 Jul 29:S0022-202X(24)01885.
    PubMed     Abstract available


  590. LOW E, Smith LA, Miwa S, Fielder E, et al
    Senescent dermal fibroblasts decrease stemness in basal keratinocytes in a bioengineered model of human full thickness skin.
    J Invest Dermatol. 2024 Jul 22:S0022-202X(24)01916.
    PubMed    


  591. GIOVANNINI S, Weibel L, Schittek B, Sinnberg T, et al
    Skin cancer induction by the antimycotic drug voriconazole is caused by impaired DNA damage detection due to chromatin compaction.
    J Invest Dermatol. 2024 Jul 22:S0022-202X(24)01920.
    PubMed     Abstract available


  592. GAUDEL C, Pisibon C, Soysouvanh F, Giuliano S, et al
    Loss of LYN is frequent in targeted-therapy resistant melanoma cells and favors metastatic properties.
    J Invest Dermatol. 2024 Jul 19:S0022-202X(24)01913.
    PubMed    


  593. MARNEROS AG
    Aplasia Cutis Congenita Pathomechanisms Reveal Key Regulators of Skin and Skin Appendage Morphogenesis.
    J Invest Dermatol. 2024 Jul 17:S0022-202X(24)01730.
    PubMed     Abstract available


  594. MCDONALD A, Karnik R, Campbell V, Davis J, et al
    Interleukin 1 Receptor-Associated Kinase 4 is Overexpressed in Hidradenitis Suppurativa Skin and Correlates with Inflammatory Biomarkers.
    J Invest Dermatol. 2024 Jul 17:S0022-202X(24)01899.
    PubMed     Abstract available


  595. MAMMADOV Y, Austin J, Shipowick T, Veldman K, et al
    A European Roundtable "Addressing Under-Prioritized Skin Diseases: Policy Responses to High-Burden Conditions", February 6, 2024.
    J Invest Dermatol. 2024 Jul 15:S0022-202X(24)01736.
    PubMed    


  596. HASSEL JC, Stanhope S, Greenshields-Watson A, Machiraju D, et al
    Tebentafusp induces a T cell driven rash in melanocyte-bearing skin as an adverse event consistent with the mechanism of action.
    J Invest Dermatol. 2024 Jul 15:S0022-202X(24)01886.
    PubMed     Abstract available


  597. FARAG A, Visvanathan S, Bachelez H, Morita A, et al
    Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterisation of Flare Treatment in EFFISAYIL(R) 1.
    J Invest Dermatol. 2024 Jul 12:S0022-202X(24)01888.
    PubMed     Abstract available


  598. KADIN ME, Hamilton RG
    Breaking the Vicious Cycle of Staphylococcal aureus Skin Colonization and Progression of Cutaneous T-Cell Lymphoma.
    J Invest Dermatol. 2024 Jul 12:S0022-202X(24)01738.
    PubMed    


  599. TRAUPE H
    Autosomal Dominant Lamellar Ichthyosis Keeps Surprising Us.
    J Invest Dermatol. 2024 Jul 11:S0022-202X(24)00446.
    PubMed    


  600. SLOMINSKI AT, Kim TK, Janjetovic Z, Slominski RM, et al
    Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin.
    J Invest Dermatol. 2024 Jul 11:S0022-202X(24)00386.
    PubMed     Abstract available


  601. LATONI DI, Geller A, Semenov YR, Ji Z, et al
    Geotemporal analysis of melanoma incidence and mortality identifies distinct clusters of trends within the United States between 2001-2019.
    J Invest Dermatol. 2024 Jul 7:S0022-202X(24)01874.
    PubMed     Abstract available


  602. MARONESE CA, Valenti M, Moltrasio C, Romagnuolo M, et al
    Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options.
    J Invest Dermatol. 2024 Jul 2:S0022-202X(24)01731.
    PubMed     Abstract available


  603. GUI H, Omiye JA, Chang CT, Daneshjou R, et al
    The Promises and Perils of Foundation Models in Dermatology.
    J Invest Dermatol. 2024;144:1440-1448.
    PubMed     Abstract available


  604. HAGERTY JR, Nambisan A, Stanley RJ, Stoecker WV, et al
    Fusion of Deep Learning with Conventional Imaging Processing: Does It Bring Artificial Intelligence Closer to the Clinic?
    J Invest Dermatol. 2024;144:1424-1427.
    PubMed    


  605. TAKAHASHI R, Kinoshita-Ise M, Yamazaki Y, Fukuyama M, et al
    Increase in CD8(+) Effector Memory T Cells Re-Expressing CD45RA Correlates with Intractability of Severe Alopecia Areata.
    J Invest Dermatol. 2024;144:1654-1657.
    PubMed    


  606. PATEL JR, Joel MZ, Lee KK, Kambala A, et al
    Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis.
    J Invest Dermatol. 2024;144:1568-1578.
    PubMed     Abstract available


  607. CONDORELLI AG, Nobili R, Muglia A, Scarpelli G, et al
    Gamma-Secretase Inhibitors Downregulate the Profibrotic NOTCH Signaling Pathway in Recessive Dystrophic Epidermolysis Bullosa.
    J Invest Dermatol. 2024;144:1522-1533.
    PubMed     Abstract available


  608. SEHEULT JN, Weybright MJ, Jevremovic D, Shi M, et al
    Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features.
    J Invest Dermatol. 2024;144:1590-1599.
    PubMed     Abstract available


  609. HONG YK, Hwang DY, Yang CC, Cheng SM, et al
    Profibrotic Subsets of SPP1(+) Macrophages and POSTN(+) Fibroblasts Contribute to Fibrotic Scarring in Acne Keloidalis.
    J Invest Dermatol. 2024;144:1491-1504.
    PubMed     Abstract available


  610. DING H, Zhou L, Zhou J, Feng J, et al
    Peripheral Mechanisms of Mechanical Itch.
    J Invest Dermatol. 2024;144:1449-1453.
    PubMed     Abstract available


  611. TANIGUCHI C, Narisada A, Ohshima Y, Inagaki K, et al
    Interactive Effects of Sex and Smoking on Palmoplantar Pustulosis: Japanese Healthcare Claim Database Study.
    J Invest Dermatol. 2024;144:1651-1653.
    PubMed    


    June 2024
  612. GU J, Zhou Z, Xu S, Pan W, et al
    Topical Application of Nitrate Ameliorates Skin Fibrosis by Regulating ST2(+)CD4(+) T Cells in Systemic Sclerosis Mouse Model.
    J Invest Dermatol. 2024 Jun 28:S0022-202X(24)01870.
    PubMed     Abstract available


  613. LAVIN L, Dusza S, Geller S
    Cutaneous T-cell lymphoma following dupilumab use - A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).
    J Invest Dermatol. 2024 Jun 28:S0022-202X(24)01865.
    PubMed    


  614. CLAUWAERT V, Verhaeghe E, De Schepper S, Haspeslagh M, et al
    Clinicopathologically Defined Naevus Subtypes and Melanoma Risk.
    J Invest Dermatol. 2024 Jun 26:S0022-202X(24)01868.
    PubMed     Abstract available


  615. BLAUVELT A, Gordon KB, Langley RG, Branigan PJ, et al
    Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2.
    J Invest Dermatol. 2024 Jun 25:S0022-202X(24)01737.
    PubMed    


  616. SHIOHARA T, Mizukawa Y
    The Neglected Beneficial Role of Sweat in Atopic Dermatitis Is Spotlighted at Last.
    J Invest Dermatol. 2024 Jun 22:S0022-202X(24)00381.
    PubMed    


  617. DENG Z, Yang Y, Suzuki K
    Federated Active Learning Framework for Ef fi cient Annotation Strategy in Skin-lesion Classification.
    J Invest Dermatol. 2024 Jun 21:S0022-202X(24)01858.
    PubMed     Abstract available


  618. JANDOVA J, Wondrak GT
    Melanotransferrin (MELTF, MFI2, CD228) expression attenuates malignant melanoma progression in the A375-Luc2 murine metastasis model and human patients.
    J Invest Dermatol. 2024 Jun 21:S0022-202X(24)01864.
    PubMed    


  619. KAO YC, Stark MS
    Challenging the Lymph Node Progression Model of Melanoma.
    J Invest Dermatol. 2024 Jun 20:S0022-202X(24)00385.
    PubMed    


  620. YANG B, Ma X, Li J
    Skin transcriptome analysis reveals potential molecular mechanisms of S100A9 in exacerbating the inflammation in rosacea.
    J Invest Dermatol. 2024 Jun 20:S0022-202X(24)01859.
    PubMed    


  621. GANIER C, Callewaert C, Matos TR, Sonkoly E, et al
    Young ESDR: Engaging and Nurturing the Next-Generation Skin Research Community.
    J Invest Dermatol. 2024 Jun 19:S0022-202X(24)00382.
    PubMed    


  622. PEREDA J, Milde Khatib C, Kezic S, Christensen MO, et al
    A Review of Atomic-Force Microscopy in Skin Barrier Function Assessment.
    J Invest Dermatol. 2024 Jun 18:S0022-202X(24)00357.
    PubMed     Abstract available


  623. OLSEN CM, Pandeya N, Miranda-Filho A, Rosenberg PS, et al
    Does sex matter? Temporal analyses of melanoma trends among men and women suggest etiologic heterogeneity.
    J Invest Dermatol. 2024 Jun 17:S0022-202X(24)01500.
    PubMed     Abstract available


  624. CVAMMEN W, Rider SD Jr, Kemp MG
    Analysis of circadian clock gene expression in epidermal human skin indicates that body location impacts rhythm amplitude.
    J Invest Dermatol. 2024 Jun 15:S0022-202X(24)01497.
    PubMed    


  625. BAO L, Perez White BE, Chang RC, Li J, et al
    FcRn inhibition reduces bullous pemphigoid anti-basement membrane zone IgG deposition and blistering in 3D human skin equivalents.
    J Invest Dermatol. 2024 Jun 15:S0022-202X(24)01504.
    PubMed    


  626. TILIGADA E, Levi-Schaffer F
    Infiltrating Basophils Tune Injured Skin Barrier Recovery.
    J Invest Dermatol. 2024 Jun 14:S0022-202X(24)00438.
    PubMed    


  627. MA X, Zhao H, Song JK, Zhang Z, et al
    Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence.
    J Invest Dermatol. 2024 Jun 13:S0022-202X(24)01735.
    PubMed     Abstract available


  628. LAMBERT KA, Clements CM, Mukherjee N, Pacheco TR, et al
    SASH1 S519N variant links skin hyperpigmentation and premature hair graying to dysfunction of melanocyte lineage.
    J Invest Dermatol. 2024 Jun 5:S0022-202X(24)00393.
    PubMed     Abstract available


  629. VORSTANDLECHNER V, Mildner M
    Much More Than Just Diabetes: The Pivotal Role of Dipeptidyl-Peptidase 4 in Skin Fibrosis.
    J Invest Dermatol. 2024 Jun 4:S0022-202X(24)00375.
    PubMed    


  630. CHEN C, Yang J, Shang R, Tang Y, et al
    Orchestration of macrophage polarization dynamics by fibroblast-secreted exosomes during skin wound healing.
    J Invest Dermatol. 2024 Jun 3:S0022-202X(24)00445.
    PubMed     Abstract available


  631. SHEN S, Sobczyk MK, Paternoster L, Brown SJ, et al
    From GWASs toward Mechanistic Understanding with Case Studies in Dermatogenetics.
    J Invest Dermatol. 2024;144:1189-1199.
    PubMed     Abstract available


  632. LONG GR, Kurdian AI, Atwood SX
    Applying Multiomics to Basosquamous Carcinoma.
    J Invest Dermatol. 2024;144:1181-1183.
    PubMed    


  633. SONG WB, Garshick MS, Barbieri JS, Shin DB, et al
    A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study.
    J Invest Dermatol. 2024;144:1405-1409.
    PubMed    


  634. WEN D, Hunjan M, Bardhan A, Harper N, et al
    Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to Severity.
    J Invest Dermatol. 2024;144:1334-1343.
    PubMed     Abstract available


  635. JUSSILA AR, Haensel D, Gaddam S, Oro AE, et al
    Acquisition of Drug Resistance in Basal Cell Nevus Syndrome Tumors through Basal to Squamous Cell Carcinoma Transition.
    J Invest Dermatol. 2024;144:1368-1377.
    PubMed     Abstract available


  636. ZHU H, Luo H, Skaug B, Tabib T, et al
    Fibroblast Subpopulations in Systemic Sclerosis: Functional Implications of Individual Subpopulations and Correlations with Clinical Features.
    J Invest Dermatol. 2024;144:1251-1261.
    PubMed     Abstract available


  637. ELHANI I, Riller Q, Boursier G, Hentgen V, et al
    A20 Haploinsufficiency: A Systematic Review of 177 Cases.
    J Invest Dermatol. 2024;144:1282-1294.
    PubMed     Abstract available


  638. KAMAL K, Xia E, Li SJ, Alavi A, et al
    Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group.
    J Invest Dermatol. 2024;144:1295-1300.
    PubMed     Abstract available


  639. ISHII K, Ishii N, Ishiko A, Hashimoto T, et al
    Pemphigus Autoantibodies to Desmocollin 3 but Not to Desmocollin 1 Directly Block Heterophilic Desmoglein/Desmocollin Transinteraction.
    J Invest Dermatol. 2024;144:1394-1397.
    PubMed    


  640. WANG XY, Jia QN, Wu MY, Liu MJ, et al
    Comparing the Efficacy of Updated Treatment Choices for Prurigo Nodularis: A Network Meta-Analysis.
    J Invest Dermatol. 2024;144:1409-1412.
    PubMed    


  641. DURAND MA, Drouin A, Bachiri K, Durand L, et al
    Enhancer of Zeste Homolog 2 Inhibition Induces HLA Class I Re-Expression in Merkel Cell Carcinoma.
    J Invest Dermatol. 2024;144:1398-1401.
    PubMed    


  642. BERTHAULT C, Gaucher S, Gouin O, Schmitt A, et al
    Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.
    J Invest Dermatol. 2024;144:1322-1333.
    PubMed     Abstract available


  643. LANGBROEK GB, Stor MLE, Janssen V, de Haan A, et al
    Characterization of Patient-Derived GNAQ Mutated Endothelial Cells from Capillary Malformations.
    J Invest Dermatol. 2024;144:1378-1388.
    PubMed     Abstract available


    May 2024
  644. NARANPANAWA N, Jayasinghe D, Sturm RA, Betz-Stablein B, et al
    Automated Detection of Pigmented Iris Freckles using a Deep Neural Network for Cutaneous Melanoma Risk.
    J Invest Dermatol. 2024 May 30:S0022-202X(24)00444.
    PubMed    


  645. SONG Z, Gao M, Li T, Zhang Y, et al
    TRPV3-activated PARP1/AIFM1/MIF axis through oxidative stress contributes to atopic dermatitis.
    J Invest Dermatol. 2024 May 30:S0022-202X(24)00384.
    PubMed     Abstract available


  646. YU LIN MO, Sampath D, Bosykh DA, Wang C, et al
    YAP/TAZ Drive Agrin-Matrix Metalloproteinase-12 Mediated Diabetic Skin Wound Healing.
    J Invest Dermatol. 2024 May 27:S0022-202X(24)00391.
    PubMed     Abstract available


  647. BEKE G, Lendvai A, Hollosi E, Braun N, et al
    Topically applied N,N-Dimethylglycine Sodium Salt Enhances Human Skin Blood Flow by Inducing Endothelial Nitric Oxide Release.
    J Invest Dermatol. 2024 May 24:S0022-202X(24)00383.
    PubMed    


  648. LEE MJ, Hammouda MB, Miao W, Okafor A, et al
    UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation.
    J Invest Dermatol. 2024 May 23:S0022-202X(24)00376.
    PubMed     Abstract available


  649. HEIKKILA A, Sliz E, Huilaja L, Reis K, et al
    GENETIC STUDY OF PSORIASIS HIGHLIGHTS ITS CLOSE LINK WITH SOCIO-ECONOMIC STATUS AND AFFECTIVE SYMPTOMS.
    J Invest Dermatol. 2024 May 17:S0022-202X(24)00358.
    PubMed     Abstract available


  650. ZENG Z, Vadivel CK, Gluud M, Namini MRJ, et al
    Keratinocytes present Staphylococcus aureus enterotoxins and promote malignant and non-malignant T cell proliferation in cutaneous T cell lymphoma.
    J Invest Dermatol. 2024 May 16:S0022-202X(24)00377.
    PubMed     Abstract available


  651. GREENSPAN LJ, Cisneros I, Weinstein BM
    Dermal Dive: An Overview of Cutaneous Wounding Techniques in Zebrafish.
    J Invest Dermatol. 2024 May 15:S0022-202X(24)00309.
    PubMed     Abstract available


  652. BORZUTZKY A, Cabalin C
    From Thin to Thick: Weight Gain in Children Feeds the Risk of Atopic Dermatitis.
    J Invest Dermatol. 2024 May 14:S0022-202X(24)00281.
    PubMed    


  653. HAYES J, Higgins CA
    Plantar Skin: A Callus Design?
    J Invest Dermatol. 2024 May 13:S0022-202X(24)00273.
    PubMed    


  654. XIAO W, Sha K, Wang M, Tan Z, et al
    SERPINB3/B4 is Increased in Psoriasis and Rosacea Lesions and has Pro-inflammatory Effects in Mouse Models of these Diseases.
    J Invest Dermatol. 2024 May 10:S0022-202X(24)00367.
    PubMed     Abstract available


  655. GORDON ER, Fahmy LM, Trager MH, Adeuyan O, et al
    From Molecules to Microbes: Tracing Cutaneous T-Cell Lymphoma Pathogenesis through Malignant Inflammation.
    J Invest Dermatol. 2024 May 4:S0022-202X(24)00262.
    PubMed     Abstract available


  656. SCHMUTH M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, et al
    Skin Barrier in Atopic Dermatitis.
    J Invest Dermatol. 2024;144:989-1000.
    PubMed     Abstract available


  657. BROWN SJ, Gudjonsson JE
    Halting the Vicious Cycle of Atopic Dermatitis: Empowered by Scientific Understanding.
    J Invest Dermatol. 2024;144:917-918.
    PubMed    


  658. STEINHOFF M, Buddenkotte J
    Flushing New Light on Rosacea.
    J Invest Dermatol. 2024;144:934-935.
    PubMed    


  659. DARCHINI-MARAGHEH E, Sinclair R
    Comment on Xia et al "Outcome Measures for Alopecia Areata".
    J Invest Dermatol. 2024;144:1165-1166.
    PubMed    


  660. SURBER C, Osterwalder U
    Response to "Sunscreens: Misconceptions and Misinformation".
    J Invest Dermatol. 2024;144:1175-1177.
    PubMed    


  661. KIM SR, Yu DA, Cho SI, Kwon O, et al
    Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease.
    J Invest Dermatol. 2024;144:1166-1169.
    PubMed    


  662. NATHANS JF, Ayers JL, Shendure J, Simpson CL, et al
    Genetic Tools for Cell Lineage Tracing and Profiling Developmental Trajectories in the Skin.
    J Invest Dermatol. 2024;144:936-949.
    PubMed     Abstract available


    April 2024
  663. MONTANO E, Tapia A, Howell MD, Ostojic J, et al
    Comparison of Tape-Stripping Platforms as Non-Invasive Solutions for Skin Biomarker Discovery.
    J Invest Dermatol. 2024 Apr 30:S0022-202X(24)00356.
    PubMed    


  664. JOHNSTON LA, Nagalla RR, Li M, Whitley SK, et al
    IL-17 Control of Cutaneous Immune Homeostasis.
    J Invest Dermatol. 2024 Apr 26:S0022-202X(23)03191.
    PubMed     Abstract available


  665. GANIER C
    Unlocking Skin's Symphony: Single-Cell and Spatial Transcriptomics Reveal the Harmonious Interplay among Diverse Cell Populations.
    J Invest Dermatol. 2024 Apr 26:S0022-202X(24)00282.
    PubMed    


  666. XIONG S, Liu F, Sun J, Gao S, et al
    Abrogation of USP9X is a potential strategy to decrease PEG10 levels and impede tumor progression in cutaneous T-cell lymphoma.
    J Invest Dermatol. 2024 Apr 25:S0022-202X(24)00307.
    PubMed     Abstract available


  667. PASANEN A, Sliz E, Huilaja L, Reimann E, et al
    Identifying atopic dermatitis risk loci in 1,094,060 individuals with sub analysis of disease severity and onset.
    J Invest Dermatol. 2024 Apr 23:S0022-202X(24)00285.
    PubMed     Abstract available


  668. KIM SR, Koh SJ, Park H
    Childhood Obesity, Weight Change, and Pediatric Immune-Mediated Skin Diseases.
    J Invest Dermatol. 2024 Apr 20:S0022-202X(24)00257.
    PubMed     Abstract available


  669. CHEN M, Li J, Ding Y, Zhang C, et al
    Skin Aging Research Enters a New Era in China.
    J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00266.
    PubMed    


  670. VAN DEN BRINK NJM, Pardow F, Meesters LD, van Vlijmen-Willems I, et al
    Electrical Impedance Spectroscopy Quantifies Skin Barrier Function in Organotypic In Vitro Epidermis Models.
    J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00293.
    PubMed     Abstract available


  671. KOMLOSI K, Glocker C, Hsu-Rehder HH, Alter S, et al
    Autosomal dominant lamellar ichthyosis due to a missense mutation in the gene NKPD1.
    J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00303.
    PubMed     Abstract available


  672. EGU DT, Schmitt T, Ernst N, Ludwig RJ, et al
    EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects Against Pemphigus Vulgaris IgG-Induced Acantholysis in Human Epidermis.
    J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00301.
    PubMed     Abstract available


  673. KOHL LM, Sumpter TL
    The ART(N) of Keratinocytes Leading Neurons into the Skin.
    J Invest Dermatol. 2024 Apr 10:S0022-202X(24)00191.
    PubMed    


  674. SAKAGUCHI S, Tsutsumi M, Akita S, Konyo M, et al
    Human Merkel cells as the initiator of mechanotransduction in skin: Linking the animal model to humans.
    J Invest Dermatol. 2024 Apr 10:S0022-202X(24)00278.
    PubMed    


  675. KHADKA VD, Markey L, Boucher M, Lieberman TD, et al
    Commensal skin bacteria exacerbate inflammation and delay skin barrier repair.
    J Invest Dermatol. 2024 Apr 9:S0022-202X(24)00277.
    PubMed     Abstract available


  676. RANDERSON-MOOR J, Davies J, Harland M, Nsengimana J, et al
    Systemic inflammation, the peripheral blood transcriptome and primary melanoma.
    J Invest Dermatol. 2024 Apr 5:S0022-202X(24)00275.
    PubMed     Abstract available


  677. BEZROOKOVE V, Kianian S, McGeever L, Jones R, et al
    The molecular evolution of melanoma distant metastases.
    J Invest Dermatol. 2024 Apr 4:S0022-202X(24)00271.
    PubMed     Abstract available


  678. GONG P, Ding Y, Li W, Yang J, et al
    Neutrophil-driven M2-like macrophages are critical for skin fibrosis in a systemic sclerosis model.
    J Invest Dermatol. 2024 Apr 3:S0022-202X(24)00274.
    PubMed     Abstract available


  679. LIU H, Wang N, Yang R, Luan J, et al
    E3 ubiquitin ligase NEDD4L negatively regulates skin tumorigenesis by inhibiting of IL-6/GP130 signaling pathway.
    J Invest Dermatol. 2024 Apr 3:S0022-202X(24)00272.
    PubMed     Abstract available


  680. PALLER AS, Scharschmidt TC, Kezic S, Irvine AD, et al
    Preclinical Atopic Dermatitis Skin in Infants: An Emerging Research Area.
    J Invest Dermatol. 2024 Apr 2:S0022-202X(24)00186.
    PubMed     Abstract available


  681. O'TOOLE EA, Kelsell DP, Caterina MJ, de Brito M, et al
    Pachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches.
    J Invest Dermatol. 2024;144:748-754.
    PubMed     Abstract available


  682. SHIU J, Lentsch G, Polleys CM, Mobasher P, et al
    Noninvasive Imaging Techniques for Monitoring Cellular Response to Treatment in Stable Vitiligo.
    J Invest Dermatol. 2024;144:912-915.
    PubMed    


  683. GUNTER SJ, Kim EJ
    Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sezary Syndrome.
    J Invest Dermatol. 2024;144:855-861.
    PubMed     Abstract available


  684. FLORA A, Jepsen R, Pham J, Frew JW, et al
    Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial.
    J Invest Dermatol. 2024;144:786-793.
    PubMed     Abstract available


  685. KNOPFEL N, Zecchin D, Richardson H, Polubothu S, et al
    GNAQ/GNA11 Mosaicism Is Associated with Abnormal Serum Calcium Indices and Microvascular Neurocalcification.
    J Invest Dermatol. 2024;144:820-832.
    PubMed     Abstract available


    March 2024
  686. GIUSTINIANI J, Anh Ta V, Belkhelouat S, Battistella M, et al
    Targeting TGF-beta activation in cutaneous T-cell lymphomas.
    J Invest Dermatol. 2024 Mar 28:S0022-202X(24)00259.
    PubMed    


  687. BATZORIG U, Chen Y, Liu Y, Fernandez-Mendez C, et al
    The SWI/SNF subunit ARID1A mediates neutrophil associated skin inflammatory responses.
    J Invest Dermatol. 2024 Mar 28:S0022-202X(24)00211.
    PubMed    


  688. XIA E, Gaurav A, Noe MH, Mostaghimi A, et al
    Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: a Cross-sectional Analysis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00212.
    PubMed    


  689. SAHEB KASHAF S, Kong HH
    Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00082.
    PubMed     Abstract available


  690. ARADI P, Kovacs G, Kemecsei E, Molnar K, et al
    Lymphatics-dependent modulation of the sensitization and elicitation phases of contact hypersensitivity.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00261.
    PubMed     Abstract available


  691. CHIU HY, Lin YJ, Huang YH
    Dipeptidyl peptidase-4 inhibitors and the risk of chronic inflammatory skin diseases in type 2 diabetes mellitus in Taiwan: a nationwide population-based cohort study.
    J Invest Dermatol. 2024 Mar 25:S0022-202X(24)00214.
    PubMed    


  692. RUAN Y, Xu C, Zhang T, Zhu L, et al
    Single-cell profiling unveils the inflammatory heterogeneity within cutaneous lesions of bullous pemphigoid.
    J Invest Dermatol. 2024 Mar 25:S0022-202X(24)00209.
    PubMed     Abstract available


  693. ISHIMARU H, Nakamoto K, Yamane M, Yamamoto T, et al
    Sweat Protects against Contact Hypersensitivity: Transient Sweat Suppression Compromises Skin Barrier Function in Mice.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00196.
    PubMed     Abstract available


  694. HONG S, Maitra P, Kadoya K, Abdolvahabi A, et al
    Quantitative Confocal Raman Microspectroscopy to Evaluate Skin Penetration of Topically Applied Substances.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00194.
    PubMed    



  695. WITHDRAWN: Expression of Concern: Zhou et al, Extracellular Vesicles of Commensal Skin Microbiota Alleviate Cutaneous Inflammation in Atopic Dermatitis Mouse Model by Re-Establishing Skin Homeostasis. J Invest Derm doi:10.1016/j.jid.2023.02.023.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00173.
    PubMed     Abstract available


  696. MARONESE CA, Costanzo A, Gilliet M, Marzano AV, et al
    Paradoxical Psoriasis: from its many faces to possible shared therapeutic targets.
    J Invest Dermatol. 2024 Mar 19:S0022-202X(24)00195.
    PubMed    


  697. LI Q, Pang B, Dang E, Wang G, et al
    Endothelial Dysfunction in Psoriasis: An Integrative Review.
    J Invest Dermatol. 2024 Mar 15:S0022-202X(24)00171.
    PubMed     Abstract available


  698. CHO SW, Malick H, Kim SJ, Grattoni A, et al
    Advances in Skin-on-a-Chip Technologies for Dermatological Disease Modeling.
    J Invest Dermatol. 2024 Mar 15:S0022-202X(24)00115.
    PubMed     Abstract available


  699. BERNSTEIN R, Gaddameedhi S
    Time Is Running Out: The Circadian Clock Suggests Sex and Aging Differences in Human Epidermis.
    J Invest Dermatol. 2024 Mar 15:S0022-202X(24)00109.
    PubMed    


  700. KAUR K, Ai R, Perry AG, Riley B, et al
    Skin cancer risk is increased by somatic mutations detected noninvasively in healthy-appearing sun-exposed skin.
    J Invest Dermatol. 2024 Mar 9:S0022-202X(24)00176.
    PubMed     Abstract available


  701. CUI YZ, Xu F, Zhou Y, Wang ZY, et al
    SPRY1 deficiency in keratinocytes induces follicular melanocyte stem cells migration to epidermis through p53/SCF/C-KIT signaling.
    J Invest Dermatol. 2024 Mar 8:S0022-202X(24)00178.
    PubMed     Abstract available


  702. BERNA-RICO E, Abbad-Jaime de Aragon C, Ballester-Martinez A, Perez-Bootello J, et al
    Monocyte-to-high-density lipoprotein ratio is associated with systemic inflammation, insulin resistance and coronary subclinical atherosclerosis in psoriasis: results from 2 observational cohorts.
    J Invest Dermatol. 2024 Mar 7:S0022-202X(24)00174.
    PubMed     Abstract available


  703. MOHAMMED NBB, Lau LS, Souchak J, Qiu S, et al
    Tumor-intrinsic galectin-3 suppresses melanoma metastasis.
    J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00169.
    PubMed     Abstract available


  704. DROLL SH, Zhang BJ, Levine MC, Xue C, et al
    CASZ1 is Essential for Skin Epidermal Terminal Differentiation.
    J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00172.
    PubMed     Abstract available


  705. ROUSEL J, Mergen C, Schoones JW, Niemeyer-van der Kolk T, et al
    Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis and ichthyosis: results from a systematic review and meta-analysis.
    J Invest Dermatol. 2024 Mar 4:S0022-202X(24)00168.
    PubMed    


  706. DAS M, Mukherjee S, Geha RS
    Phosphodiesterase 4 Inhibitors, Basophils, and Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 3:S0022-202X(24)00096.
    PubMed    


  707. BRAHIMI N, Piguet V
    Autophagy during Severe Acute Respiratory Syndrome Coronavirus 2 Induced Leukocytoclastic Vasculitis: New Insights.
    J Invest Dermatol. 2024;144:441-443.
    PubMed    


  708. FLESHER JL, Fisher DE
    MAPK-Activating Gene Fusions in Congenital Nevi.
    J Invest Dermatol. 2024;144:446-448.
    PubMed    


  709. GOLOB-SCHWARZL N, Pilic J, Benezeder T, Bordag N, et al
    Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment.
    J Invest Dermatol. 2024;144:500-508.
    PubMed     Abstract available


  710. WANG S, Wang R, Shang P, Zhu X, et al
    Whole-Exome Sequencing Reveals the Genomic Profile and IL6ST Variants as a Prognostic Biomarker of Paraneoplastic Pemphigus-Associated Unicentric Castleman Disease.
    J Invest Dermatol. 2024;144:585-592.
    PubMed     Abstract available


  711. BETTUZZI T, Hoisnard L, Beytout Q, Ingen-Housz-Oro S, et al
    Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database.
    J Invest Dermatol. 2024;144:708-710.
    PubMed    


  712. VALEI LOPES DE OLIVEIRA E, Tremeschin de Almeida Vieira F, de Souza Pinhel MA, Gripp AC, et al
    Differential FCGR2A and FCGR3A Alleles/Genotypes in Pemphigus Vulgaris and Pemphigus Foliaceus in Southeastern Brazil.
    J Invest Dermatol. 2024;144:702-705.
    PubMed    


  713. BRITO S, Heo H, Cha B, Lee SH, et al
    The Slc45a4 Gene Regulates Pigmentation in a Manner Distinct from that of the OCA4 Gene Slc45a2.
    J Invest Dermatol. 2024;144:720-722.
    PubMed    


  714. EZZEDINE K, Soliman AM, Li C, Camp HS, et al
    Economic Burden among Patients with Vitiligo in the United States: A Retrospective Database Claims Study.
    J Invest Dermatol. 2024;144:540-546.
    PubMed     Abstract available


  715. WANG X, Mao D, Jia J, Zhang J, et al
    Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes.
    J Invest Dermatol. 2024;144:509-519.
    PubMed     Abstract available


  716. BERTHY C, Gagnoux-Palacios L, Madrange M, Bodemer C, et al
    PRIMA-1(MET)/APR-246 Can Partially Rescue In Vitro Cell Adhesion of Patient-Derived Junctional Epidermolysis Bullosa Epidermal Cells.
    J Invest Dermatol. 2024;144:717-719.
    PubMed    


  717. YU Z, Vieyra-Garcia P, Benezeder T, Crouch JD, et al
    Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides.
    J Invest Dermatol. 2024;144:621-632.
    PubMed     Abstract available


  718. ZRELSKI MM, Hosele S, Kustermann M, Fichtinger P, et al
    Plectin Deficiency in Fibroblasts Deranges Intermediate Filament and Organelle Morphology, Migration, and Adhesion.
    J Invest Dermatol. 2024;144:547-562.
    PubMed     Abstract available


    February 2024
  719. LARSON EL, DeMeo DP, Young AB, Margevicius S, et al
    Circulating Monocytes are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast.
    J Invest Dermatol. 2024 Feb 29:S0022-202X(24)00166.
    PubMed     Abstract available


  720. GALLO RL, Horswill AR
    Staphylococcus aureus: The Bug Behind the Itch in Atopic Dermatitis.
    J Invest Dermatol. 2024 Feb 29:S0022-202X(24)00002.
    PubMed     Abstract available


  721. STANDER S, Schmelz M
    Skin Innervation.
    J Invest Dermatol. 2024 Feb 24:S0022-202X(24)00085.
    PubMed     Abstract available


  722. OLSEN CM, Pandeya N, Whiteman DC
    Trends in age at melanoma diagnosis according to thickness and histologic subtype have implications for causality and control.
    J Invest Dermatol. 2024 Feb 21:S0022-202X(24)00116.
    PubMed    


  723. GRIT JL, Turner L, Essenburg CJ, Gallik KL, et al
    Ex-vivo patient-derived explant model for neurofibromatosis type 1-related cutaneous neurofibromas.
    J Invest Dermatol. 2024 Feb 21:S0022-202X(24)00117.
    PubMed     Abstract available


  724. CHEN Q, Rong H, Zhang L, Wang Y, et al
    KLF2 Orchestrates Pathological Progression of Infantile Hemangioma through Hemangioma Stem Cell Fate Decisions.
    J Invest Dermatol. 2024 Feb 19:S0022-202X(24)00113.
    PubMed     Abstract available


    December 2023
  725. NAKAI S, Kume M, Matsumura Y, Koguchi-Yoshioka H, et al
    CD69 is indispensable for the development of functional local immune memory in murine contact hypersensitivity.
    J Invest Dermatol. 2023 Dec 20:S0022-202X(23)03190.
    PubMed     Abstract available


    November 2023
  726. SOUTH AP, Laimer M, Gueye M, Sui JY, et al
    Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa.
    J Invest Dermatol. 2023;143:2108-2119.
    PubMed     Abstract available


  727. HELM M, Schmidt M, Del Duca E, Liu Y, et al
    Repurposing DPP4 Inhibition to Improve Hair Follicle Activation and Regeneration.
    J Invest Dermatol. 2023;143:2132-2144.
    PubMed     Abstract available


  728. WANG Y, Hotz A, Esser PR, Fischer J, et al
    Amino Acid Substitution in the Cysteine-Rich Region of the Integrin beta4 Subunit Causes Late-Onset Mild Junctional Epidermolysis Bullosa without Extracutaneous Involvement.
    J Invest Dermatol. 2023;143:2233-2242.
    PubMed     Abstract available


  729. YU J, Song P, Bai Y, Dang E, et al
    CD36-SREBP1 Axis Mediates TSLP Production in Obesity-Exacerbated Atopic Dermatitis.
    J Invest Dermatol. 2023;143:2153-2162.
    PubMed     Abstract available


  730. EL MAHI Y, Varin A, Vetter M, Dal Zuffo L, et al
    Resolved Psoriasis with Abundant Oleic Acid in Stratum Corneum Exhibits Lower T-Cell-Driven IL-17 Signature.
    J Invest Dermatol. 2023;143:2145-2152.
    PubMed     Abstract available


  731. LIN FJ, Huang YH, Tsao CH, Hsieh WC, et al
    Galectin-12 Regulates Immune Responses in the Skin through Sebaceous Glands.
    J Invest Dermatol. 2023;143:2120-2131.
    PubMed     Abstract available


  732. HUANG L, Wang X, Pei S, Li X, et al
    Single-Cell Profiling Reveals Sustained Immune Infiltration, Surveillance, and Tumor Heterogeneity in Infiltrative Basal Cell Carcinoma.
    J Invest Dermatol. 2023;143:2283-2294.
    PubMed     Abstract available


  733. GEORGE CD, Tokez S, Hollestein L, Pardo LM, et al
    Longitudinal Assessment of the Prevalence of Actinic Keratosis and Extensive Risk Factor Evaluation: An Update from the Rotterdam Study.
    J Invest Dermatol. 2023;143:2193-2203.
    PubMed     Abstract available


  734. OZEKI T, Muramatsu K, Yoshimoto N, Ujiie I, et al
    Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors.
    J Invest Dermatol. 2023;143:2219-2225.
    PubMed     Abstract available


  735. FERTITTA L, Sarin KY, Bergqvist C, Patel E, et al
    cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.
    J Invest Dermatol. 2023;143:2226-2232.
    PubMed     Abstract available


  736. THEIN D, Roseno NAL, Maul JT, Wu JJ, et al
    Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment - a Nationwide Cohort Study.
    J Invest Dermatol. 2023;143:2211-2218.
    PubMed     Abstract available


    May 2023
  737. GUO Z, Liu Q, Lan S, Niu N, et al
    Clinicopathological Features and Prognosis of Melanoma in Northeast China: a region-based cohort study of 229 consecutive cases.
    J Invest Dermatol. 2023 May 17:S0022-202X(23)02069.
    PubMed     Abstract available


    March 2023
  738. SALAMITO M, Gillet B, Syx D, Vaganay E, et al
    NRF2 Shortage in Human Skin Fibroblasts Dysregulates Matrisome Gene Expression and Affects Collagen Fibrillogenesis.
    J Invest Dermatol. 2023;143:386-397.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum